淫羊藿素对MC3T3-E1Subclone14细胞分化及相关信号通路的影响
|
摘要
目的:
淫羊藿素为补肾强骨中药淫羊藿的主要成分淫羊藿苷在动物体内代谢后脱去糖基的活性成分,可能是淫羊藿口服吸收后主要发挥药理活性的成分,对其研究更符合淫羊藿临床多口服给药的用药方式。目前其对成骨细胞作用机理的研究尚未见报道。本研究观察淫羊藿素对MC3T3-ElSubclone14前体成骨细胞株增殖、分化的影响,以及观察它对与分化相关的雌激素受体信号通路、p38MAPK信号通路、BMPs/smads信号通路的影响,明确淫羊藿素作用于成骨细胞而影响骨代谢的具体靶点,对于评价淫羊藿治疗骨质疏松等骨代谢疾病的有效性提供细胞分子学依据。
方法:
1.MC3T3-ElSubclone14前体成骨细胞株的培养及活性观察。
2.运用MTT法检测淫羊藿素对MC3T3-ElSubclone14的细胞毒性,确定实验用的药物剂量。
3.应用WST-8细胞活力方法、BrdU流式细胞仪方法检测淫羊藿素对MC3T3-ElSubclone14细胞增殖的影响。
4.应用pNPP方法检测淫羊藿素对MC3T3-ElSubclone14细胞碱性磷酸酶活性的影响,运用双抗夹心ELISA方法检测淫羊藿素对MC3T3-ElSubclone14细胞Ⅰ型胶原和骨钙素的影响,运用茜素红染色计数矿化结节的方法评价淫羊藿素对MC3T3-ElSubclone14细胞矿化的影响。
5.运用ER受体阻断剂ICI182780阻断ER受体信号后,检测淫羊藿素对MC3T3-ElSubclone14细胞碱性磷酸酶活性、Ⅰ型胶原和骨钙素的影响,评价ER受体信号在淫羊藿素对MC3T3-ElSubclone14细胞分化过程中的作用。
6.运用p38MAPK受体阻断剂SB203580阻断p38MAPK信号后,检测淫羊藿素对MC3T3-ElSubclone14细胞碱性磷酸酶活性、Ⅰ型胶原和骨钙素的影响,评价p38MAPK信号在淫羊藿素对MC3T3-ElSubclone14细胞分化过程中的作用。
7.实时荧光PCR检测淫羊藿素对BMP-2、4、7mRNA的表达。运用BMPs受体阻断剂Noggin阻断BMPs/Smads信号后,检测淫羊藿素对MC3T3-ElSubclone14细胞表达碱性磷酸酶活性、Ⅰ型胶原和骨钙素的影响,评价BMPs/Smads信号在淫羊藿素对MC3T3-ElSubclone14细胞分化过程中的作用。
8.Western-blot检测ER受体阻断剂ICI182780阻断ER受体信号后,淫羊藿素对p38和Smad1/5/8的蛋白磷酸化情况,评价它们和ER受体信号的关系。
结果:
1.MC3T3-ElSubclone14前体成骨细胞株,在具有分化条件的培养基中可以向成骨细胞分化。
2.淫羊藿素对MC3T3-ElSubclone14细胞毒性的检测发现,IC50浓度为10~(0.154)mol/L,10~(-5.93)mol/L浓度以下则对细胞基本上无抑制作用,因此实验药物浓度选择10~(-8)、10~(-7)、10~(-6)mol/L 0.01μM、0.1μM、1μM)为梯度浓度。
3.WST-8和BrdU流式细胞仪检测发现,淫羊藿素0.01μM、0.1μM、1μM浓度组的MC3T3-ElSubclone14的细胞活力和细胞增殖指数与对照组比较,在统计学上无显著差异(P＞0.05)。
4.在作用48或72小时后,淫羊藿素0.01μM、0.1μM、1μM浓度组MC3T3-ElSubclone14细胞的碱性磷酸酶、Ⅰ型胶原和骨钙素与对照组比较,在统计学上有显著差异(P＜0.01或0.05);淫羊藿素作用10天或14天后,各组的矿化结节计数和对照组比较,在统计学上有显著差异(P＜0.01)。
5.运用ER受体阻断剂ICI182780阻断ER受体信号后,1μM浓度的淫羊藿素促进MC3T3-ElSubclone14细胞分化的特性明显下降,和单纯应用淫羊藿素组在统计学上有显著差异(P＜0.01);运用p38MAPK受体阻断剂SB203580阻断p38MAPK信号后,1μM浓度的淫羊藿素促进MC3T3-ElSubclone14细胞分化的特性明显下降,和单纯应用淫羊藿素组在统计学上有显著差异(P＜0.01);运用BMPs受体阻断剂Noggin阻断BMPs/Smads信号后,1μM浓度的淫羊藿素促进MC3T3-ElSubclone14细胞分化的特性明显下降,和单纯应用淫羊藿素组在统计学上有显著差异(P＜0.01)。
6.淫羊藿素可以提高BMP-2mRNA的表达,并随着浓度的增高而增高,和对照组比较,在统计学上有明显差异(P＜0.01或0.05),1μM浓度的淫羊藿素可以提高BMP-4mRNA的表达(P＜0.05),但对BMP-7mRNA无作用(P＞0.01)。
7.Western-blot检测发现运用ER受体阻断剂ICI182780阻断ER受体信号后,p38和Smad1/5/8的磷酸化明显减弱。
结论:
1.一定浓度(0.01μM、0.1μM、1μM)的ICT对MC3T3-ElSubclone14细胞增殖无明显促进作用。
2.一定浓度(0.01μM、0.1μM、1μM)的ICT可以促进MC3T3-ElSubclone14细胞分化,促进其矿化。
3.ICT促进MC3T3-ElSubclone14细胞分化和ER受体信号通路、p38MAPK信号通路、BMPs/Smads信号通路密切相关。
4.在ICT促进MC3T3-ElSubclone14细胞分化的过程中,ER受体信号通路在p38MAPK信号通路和BMPs/Smads信号通路的上游。
5.实验结果提示ICT在MC3T3-ElSubclone14细胞分化过程中所显示的主要作用可能和它的类雌激素样活性有关。
Objective:
Epimedium grandiflorum Morr,a traditional Chinese herb,was effective to treatment many diseases of bone.Icariin,a principal flavonoid glycoside in Epimedium grandiflorum Morr,is metabolized to Icaritin in vivo.Icaritin may have beneficial effects on bone mass.but its role and mechanism in osteoblasts is unclear.This study is to observe the effects of icaritin on the proliferation and differentiation of MC3T3-E1Subclonel4,a pre-osteoblasts cell line,and observe the effects on ER, p38MAPK and BMPs/Smads signaling pathways which were closely related to differentiation of osteoblasts.To define targets of icaritin on osteoblasts,which can provide cellular and molecular evidences for Epimedium grandiflorum Morr treating osteoporosis and other bone metabolic diseases.
Methods:
1.MC3T3-E1Subclonel4 was cultured and its biological activity was observed.
2.MTT method was used to observe cytotoxicity of Icaritin,and to determine the experimental concentration of Icaritin in the Medium.
3.WST-8 method and BrdU method were used to observe cell activity and proliferation of MC3T3-E1Subclonel4 cells after treating with different concentration of Icaritin.
4.pNPP method was used to observe ALP activity of MC3T3-E1Subclonel4 cells after treating with different concentration of Icaritin.ELISA kit was used to observe TypeⅠcollagen and osteocalcin activity of MC3T3-E1Subclonel4 cells after treating with different concentration of Icaritin.Alizarin dyeing was used to observe mineralization of MC3T3-E1Subclonel4 cells after treating with different concentration of Icaritin.
5.After ER Signaling pathways was blocked by ICI182780,p38MAPK Signaling pathways was blocked by SB203580 respectively,ALP,TypeⅠcollagen and osteocalcin activity of MC3T3-E 1Subclonel4 cell were observed after treating with Icaritin.
6.Real-time PCR was used to observe the mRNA relative levels of BMP-2、4、7 after treating with Icaritin.After BMPs/Smads Signaling pathways was blocked by noggin,ALP,Type I collagen and osteocalcin activity of MC3T3-E1Subclonel4 cells were observed after treating with Icaritin.
7.Western-blot was used to observe p38 and Smadl/5/8 protein phosphorylation after ER Signaling pathways was blocked by ICI182780 after treating with Icaritin.
Results:
1.MC3T3-E1Subclonel4 cells was induced successfully into osteoblasts in medium of inducing conditions.
2.IC50 of Icaritin's concentration in medium in the cytotoxicity test was 10~(0.154) mol/L.Less than the concentration of 10~(-5.93)mol/L,Icaritin can't inhibit the growth of MC3T3-E 1Subclone 14 cells.
3.Cell activity and Proliferation index of MC3T3-E1Subclonel4 cells of Icaritin (0.01μM、0.1μM、1μM) groups have no different with control group after 48 and 72hours(P＞0.05).
4.ALP,TypeⅠcollagen and osteocalcin activity oflcaritin(0.01μM、0.1μM、1μM) groups were higher than control group after 48 or 72hours(P＜0.01or 0.05). Mineralized nodus weren higher control group after 10 or 14days(P＜0.01).
5.ALP,TypeⅠcollagen and osteocalcin activity of MC3T3-E1Subclone 14 cell of experimental group(Icaritin+blocker) were less than Icaritin group after ER Signaling pathways was blocked by ICI182780,p38MAPK Signaling pathways was blocked by SB203580 respectively(P＜0.01).
6.The mRNA levels of BMP-2 and BMP- 4 of Icaritin group was higher than control group(P＜0.01 or 0.05),but the mRNA levels of BMP-7 of all groups have no significant difference(P＞0.05).
7.ALP,TypeⅠcollagen and osteocalcin activity of MC3T3-E1Subclonel4 cell of experimental group(Icaritin+blocker) were less than Icaritin group after BMPs/Smads Signaling pathways was blocked by noggin(P＜0.01 or 0.05).
8.p38 and Smadl/5/8 protein phosphorylation of icaritin -induced decreased significantly after ER Signaling pathways was blocked by ICI182780.
Conclusions:
1.Icaritin(0.01μM、0.1μM、1μM) can't increase activity and proliferation index of MC3T3-E 1Subclone 14 cells.
2.Icaritin(0.01μM、0.1μM、1μM) can increase differentiation and mineralization of MC3T3-E1Subclone 14 cells.
3.Icaritin's role in the promotion of MC3T3-E1Subclonel4 cells differentiation is closely related to ER,p38MAPK and BMPs/Smads Signaling pathways.
4.In the differentiation process,ER Signaling pathways may be take place upstream of p38MAPK and BMPs/Smads Signaling pathways.
5.Icaritin can increase differentiation of MC3T3-E 1Subclone 14 cells may be for its estrogen-like activity.
淫羊藿素为补肾强骨中药淫羊藿的主要成分淫羊藿苷在动物体内代谢后脱去糖基的活性成分,可能是淫羊藿口服吸收后主要发挥药理活性的成分,对其研究更符合淫羊藿临床多口服给药的用药方式。目前其对成骨细胞作用机理的研究尚未见报道。本研究观察淫羊藿素对MC3T3-ElSubclone14前体成骨细胞株增殖、分化的影响,以及观察它对与分化相关的雌激素受体信号通路、p38MAPK信号通路、BMPs/smads信号通路的影响,明确淫羊藿素作用于成骨细胞而影响骨代谢的具体靶点,对于评价淫羊藿治疗骨质疏松等骨代谢疾病的有效性提供细胞分子学依据。
方法:
1.MC3T3-ElSubclone14前体成骨细胞株的培养及活性观察。
2.运用MTT法检测淫羊藿素对MC3T3-ElSubclone14的细胞毒性,确定实验用的药物剂量。
3.应用WST-8细胞活力方法、BrdU流式细胞仪方法检测淫羊藿素对MC3T3-ElSubclone14细胞增殖的影响。
4.应用pNPP方法检测淫羊藿素对MC3T3-ElSubclone14细胞碱性磷酸酶活性的影响,运用双抗夹心ELISA方法检测淫羊藿素对MC3T3-ElSubclone14细胞Ⅰ型胶原和骨钙素的影响,运用茜素红染色计数矿化结节的方法评价淫羊藿素对MC3T3-ElSubclone14细胞矿化的影响。
5.运用ER受体阻断剂ICI182780阻断ER受体信号后,检测淫羊藿素对MC3T3-ElSubclone14细胞碱性磷酸酶活性、Ⅰ型胶原和骨钙素的影响,评价ER受体信号在淫羊藿素对MC3T3-ElSubclone14细胞分化过程中的作用。
6.运用p38MAPK受体阻断剂SB203580阻断p38MAPK信号后,检测淫羊藿素对MC3T3-ElSubclone14细胞碱性磷酸酶活性、Ⅰ型胶原和骨钙素的影响,评价p38MAPK信号在淫羊藿素对MC3T3-ElSubclone14细胞分化过程中的作用。
7.实时荧光PCR检测淫羊藿素对BMP-2、4、7mRNA的表达。运用BMPs受体阻断剂Noggin阻断BMPs/Smads信号后,检测淫羊藿素对MC3T3-ElSubclone14细胞表达碱性磷酸酶活性、Ⅰ型胶原和骨钙素的影响,评价BMPs/Smads信号在淫羊藿素对MC3T3-ElSubclone14细胞分化过程中的作用。
8.Western-blot检测ER受体阻断剂ICI182780阻断ER受体信号后,淫羊藿素对p38和Smad1/5/8的蛋白磷酸化情况,评价它们和ER受体信号的关系。
结果:
1.MC3T3-ElSubclone14前体成骨细胞株,在具有分化条件的培养基中可以向成骨细胞分化。
2.淫羊藿素对MC3T3-ElSubclone14细胞毒性的检测发现,IC50浓度为10~(0.154)mol/L,10~(-5.93)mol/L浓度以下则对细胞基本上无抑制作用,因此实验药物浓度选择10~(-8)、10~(-7)、10~(-6)mol/L 0.01μM、0.1μM、1μM)为梯度浓度。
3.WST-8和BrdU流式细胞仪检测发现,淫羊藿素0.01μM、0.1μM、1μM浓度组的MC3T3-ElSubclone14的细胞活力和细胞增殖指数与对照组比较,在统计学上无显著差异(P＞0.05)。
4.在作用48或72小时后,淫羊藿素0.01μM、0.1μM、1μM浓度组MC3T3-ElSubclone14细胞的碱性磷酸酶、Ⅰ型胶原和骨钙素与对照组比较,在统计学上有显著差异(P＜0.01或0.05);淫羊藿素作用10天或14天后,各组的矿化结节计数和对照组比较,在统计学上有显著差异(P＜0.01)。
5.运用ER受体阻断剂ICI182780阻断ER受体信号后,1μM浓度的淫羊藿素促进MC3T3-ElSubclone14细胞分化的特性明显下降,和单纯应用淫羊藿素组在统计学上有显著差异(P＜0.01);运用p38MAPK受体阻断剂SB203580阻断p38MAPK信号后,1μM浓度的淫羊藿素促进MC3T3-ElSubclone14细胞分化的特性明显下降,和单纯应用淫羊藿素组在统计学上有显著差异(P＜0.01);运用BMPs受体阻断剂Noggin阻断BMPs/Smads信号后,1μM浓度的淫羊藿素促进MC3T3-ElSubclone14细胞分化的特性明显下降,和单纯应用淫羊藿素组在统计学上有显著差异(P＜0.01)。
6.淫羊藿素可以提高BMP-2mRNA的表达,并随着浓度的增高而增高,和对照组比较,在统计学上有明显差异(P＜0.01或0.05),1μM浓度的淫羊藿素可以提高BMP-4mRNA的表达(P＜0.05),但对BMP-7mRNA无作用(P＞0.01)。
7.Western-blot检测发现运用ER受体阻断剂ICI182780阻断ER受体信号后,p38和Smad1/5/8的磷酸化明显减弱。
结论:
1.一定浓度(0.01μM、0.1μM、1μM)的ICT对MC3T3-ElSubclone14细胞增殖无明显促进作用。
2.一定浓度(0.01μM、0.1μM、1μM)的ICT可以促进MC3T3-ElSubclone14细胞分化,促进其矿化。
3.ICT促进MC3T3-ElSubclone14细胞分化和ER受体信号通路、p38MAPK信号通路、BMPs/Smads信号通路密切相关。
4.在ICT促进MC3T3-ElSubclone14细胞分化的过程中,ER受体信号通路在p38MAPK信号通路和BMPs/Smads信号通路的上游。
5.实验结果提示ICT在MC3T3-ElSubclone14细胞分化过程中所显示的主要作用可能和它的类雌激素样活性有关。
Objective:
Epimedium grandiflorum Morr,a traditional Chinese herb,was effective to treatment many diseases of bone.Icariin,a principal flavonoid glycoside in Epimedium grandiflorum Morr,is metabolized to Icaritin in vivo.Icaritin may have beneficial effects on bone mass.but its role and mechanism in osteoblasts is unclear.This study is to observe the effects of icaritin on the proliferation and differentiation of MC3T3-E1Subclonel4,a pre-osteoblasts cell line,and observe the effects on ER, p38MAPK and BMPs/Smads signaling pathways which were closely related to differentiation of osteoblasts.To define targets of icaritin on osteoblasts,which can provide cellular and molecular evidences for Epimedium grandiflorum Morr treating osteoporosis and other bone metabolic diseases.
Methods:
1.MC3T3-E1Subclonel4 was cultured and its biological activity was observed.
2.MTT method was used to observe cytotoxicity of Icaritin,and to determine the experimental concentration of Icaritin in the Medium.
3.WST-8 method and BrdU method were used to observe cell activity and proliferation of MC3T3-E1Subclonel4 cells after treating with different concentration of Icaritin.
4.pNPP method was used to observe ALP activity of MC3T3-E1Subclonel4 cells after treating with different concentration of Icaritin.ELISA kit was used to observe TypeⅠcollagen and osteocalcin activity of MC3T3-E1Subclonel4 cells after treating with different concentration of Icaritin.Alizarin dyeing was used to observe mineralization of MC3T3-E1Subclonel4 cells after treating with different concentration of Icaritin.
5.After ER Signaling pathways was blocked by ICI182780,p38MAPK Signaling pathways was blocked by SB203580 respectively,ALP,TypeⅠcollagen and osteocalcin activity of MC3T3-E 1Subclonel4 cell were observed after treating with Icaritin.
6.Real-time PCR was used to observe the mRNA relative levels of BMP-2、4、7 after treating with Icaritin.After BMPs/Smads Signaling pathways was blocked by noggin,ALP,Type I collagen and osteocalcin activity of MC3T3-E1Subclonel4 cells were observed after treating with Icaritin.
7.Western-blot was used to observe p38 and Smadl/5/8 protein phosphorylation after ER Signaling pathways was blocked by ICI182780 after treating with Icaritin.
Results:
1.MC3T3-E1Subclonel4 cells was induced successfully into osteoblasts in medium of inducing conditions.
2.IC50 of Icaritin's concentration in medium in the cytotoxicity test was 10~(0.154) mol/L.Less than the concentration of 10~(-5.93)mol/L,Icaritin can't inhibit the growth of MC3T3-E 1Subclone 14 cells.
3.Cell activity and Proliferation index of MC3T3-E1Subclonel4 cells of Icaritin (0.01μM、0.1μM、1μM) groups have no different with control group after 48 and 72hours(P＞0.05).
4.ALP,TypeⅠcollagen and osteocalcin activity oflcaritin(0.01μM、0.1μM、1μM) groups were higher than control group after 48 or 72hours(P＜0.01or 0.05). Mineralized nodus weren higher control group after 10 or 14days(P＜0.01).
5.ALP,TypeⅠcollagen and osteocalcin activity of MC3T3-E1Subclone 14 cell of experimental group(Icaritin+blocker) were less than Icaritin group after ER Signaling pathways was blocked by ICI182780,p38MAPK Signaling pathways was blocked by SB203580 respectively(P＜0.01).
6.The mRNA levels of BMP-2 and BMP- 4 of Icaritin group was higher than control group(P＜0.01 or 0.05),but the mRNA levels of BMP-7 of all groups have no significant difference(P＞0.05).
7.ALP,TypeⅠcollagen and osteocalcin activity of MC3T3-E1Subclonel4 cell of experimental group(Icaritin+blocker) were less than Icaritin group after BMPs/Smads Signaling pathways was blocked by noggin(P＜0.01 or 0.05).
8.p38 and Smadl/5/8 protein phosphorylation of icaritin -induced decreased significantly after ER Signaling pathways was blocked by ICI182780.
Conclusions:
1.Icaritin(0.01μM、0.1μM、1μM) can't increase activity and proliferation index of MC3T3-E 1Subclone 14 cells.
2.Icaritin(0.01μM、0.1μM、1μM) can increase differentiation and mineralization of MC3T3-E1Subclone 14 cells.
3.Icaritin's role in the promotion of MC3T3-E1Subclonel4 cells differentiation is closely related to ER,p38MAPK and BMPs/Smads Signaling pathways.
4.In the differentiation process,ER Signaling pathways may be take place upstream of p38MAPK and BMPs/Smads Signaling pathways.
5.Icaritin can increase differentiation of MC3T3-E 1Subclone 14 cells may be for its estrogen-like activity.
引文
[1]李文魁,张如意,肖培根.淫羊藿属药用植物研究进展[J].国外医药·植物学分册1993,8(4):147-154
[2]刘信顺,杨滨.淫羊藿属植物的化学成分[J].中草药1990,21(9):36-39
[3]林新,李文魁,肖培根.淫羊藿的研究新进展[J].中国药学杂志1997,32(8):449-451
[4]刘佳,吴克枫,俞红,李锦兰,阮海星.淫羊藿对小鼠免疫功能的调节作用[J].卫生研究1997,26(6):399-340
[5]程庆,陈香美,师锁柱,于力方.中药淫羊藿对慢性肾衰大鼠免疫病理及细胞外基质的影响[J].中华微生物学和免疫杂志1993,13(3):199-121
[6]孙奕,王景明,骆永珍.淫羊藿对小鼠MPS吞噬功能和红细胞免疫粘附功能的影响及相关性研究[J].中国免疫学杂志2002,(18):114-116
[7]刘佳,吴克枫.淫羊藿煎汁对小鼠免疫功能的影响[J].贵阳医学院学报1996,21(1):18-21
[8]张玲娟,沈自尹,蔡定芳,陈晓红,沈时谋.淫羊藿对大鼠下丘脑-垂体-肾上腺-胸腺轴抑制模型的影响[J].中医杂志1996,37(10):621-623
[9]陆军,崔爱东,蔡良.淫羊藿对血液透析患者T淋巴细胞亚群的影响[J].中西医结合实用临床急救.1998,5(4):148-150
[10]熊平源,郭凯文,唐朝辉,白惠卿.淫羊藿对小鼠免疫功能的调节作用[J].数理医药学杂志2007,20(1):50-52
[11]汪年松,唐令诠,竺艳娟,廖履坦.淫羊藿对血液透析HCV感染者细胞免疫功能的作用[J].上海免疫学杂志2001,21(2):115-116
[12]苗起芬,马俐儒,赵春华,胡宇华.淫羊藿对慢性肾盂肾炎患者血清白介素6、白介素8的影响[J].中国老年学杂志2005,10:1177-1178
[13]陈玉春.补益中药调控IL-2产生及其作用的实验研究.福建中医学院学报1993,3(4):218-221
[14]陈香美,廖洪军,李宁虹,卢英杰.慢性肾衰大鼠IL-2基因表达的改变及淫羊藿的调节作用[J].解放军医学杂志1995,20(5):353-356
[15]廖洪军,陈香美,李文戈,程庆.淫羊藿对血液透析患者生存质量及细胞免疫功能的影响[J].中国中西医结合杂志1995,15(4):202-205
[16]陈香美,周美华,王建中,段永刚.血液透析患者sIL-2R、IL-6变化与淫羊藿的免疫调节作用[J].中华内科杂志1995;34(2):102-104
[17]肖崇厚,孙奕,骆永珍.川产淫羊藿对羟基脲阳虚小鼠IL-2活性的影响[J].中国免疫学杂志1995;11(6):373-376
[18]赵福东,董竞成,崔焱,谢瑾玉,吴金峰,宫兆华,巫善美.淫羊藿对哮喘大鼠神经内分泌免疫网络若干指标的影响[J].中国实验方剂学杂志2007,13(9):44-46
[19]骆永珍,袁必文,姚玉龙,孙奕,沈文龙.“外气”与淫羊藿对“阳虚”小鼠NK细胞活性的影响[J].云南中医学院学报1996,19(3):31-35
[20]陈玮,邹焰,姜东.人参、淫羊藿增强小鼠免疫功能的协同作用[J].遵义医学院学报2001,24(2):124-125
[21]郭英,谢建平,曾博程,莫正纪.淫羊藿提取物对大鼠急性心肌缺血的影响[J].华西药学杂志2005,20(1):44-45
[22]郭英,谢建平,莫正纪.淫羊藿提取物对急性心肌缺血大鼠血流动力学的影响[J].中国医药工业杂志2005,36(5):286-287
[23]张丽君,刘宏权,吕文伟,石毅.淫羊藿提取物对犬急性心肌缺血的保护作用[J].中华老年心脑血管病杂志2006,8(11):765-767
[24]岳攀,王秋娟,胡哲一,孔令义.淫羊藿提取物对犬血流动力学的影响[J].中国天然药物2004,2(3):184-188
[25]杨远友,刘宁,莫正纪,谢建平,廖家莉,莫尚武.淫羊藿对大鼠内脏器官PDC钙通道及其心肌缺血性损伤的影响[J].四川大学学报(自然科学版)2005,42(1):122-127
[26]王少峡,房蓓,张志国.淫羊藿提取物对大鼠胸主动脉Ca2+内流量的影响[J].天津中医学院学报2003,22(2):16-18
[27]于永红,胡昌兴,孟卫星,张国安,王当金.茵陈、赤芍、三棱、淫羊藿对家兔实验性动脉粥样硬化病灶的消退作用及原癌基因C-mye、C-fos、V-sis表达的影响[J].湖北民族学院学报(医学版)2001,18(2):4-6
[28]刘崇铭,王敏,梁利春.淫羊藿黄酮对脑血管与脑缺血的作用[J].沈阳药学院学报1995,12(3):19-23
[29]宫洪涛,郭可红,王宝亮,秦润笋,张振强.淫羊藿注射液穴位注射治疗血管性痴呆60例疗效观察[J].中医杂志2003,44(2):103-104
[30]严金玲,钟有添,曾靖,陈秋英,赖飞,黄贤华.淫羊藿水提取液对小鼠睡眠功能和自发活动的影响[J].中国临床康复2004,8(33):7460-7461
[31]Peng YL,Zhu XY,Xeng J.et al.Effects ofherba epimedium extract om spontaneous activity and sleep function of mice[J].Chinese Journal of Clinical Rehabilitation 2005,9(40):164-166
[32]赖飞,曾靖,黄贤华,叶和扬,朱遵平,杨敬格.淫羊藿水提取液中枢抑制作用的研究 [J].赣南医学院学报2003,23(3):268-270
[33]曾靖,赖飞,叶和杨,黄贤华.淫羊藿水提取液局部麻醉作用的研究[J].赣南医学院学报2004,24(1):1-3
[34]李良东,黄志华,曾靖,周俐,周青.淫羊藿水提取液镇痛作用的研究[J].赣南医学院学报2004,24(1):14-15
[35]钟海波,潘颖,孔令东.淫羊藿提取物抗抑郁作用研究[J].中草药2005,36(10):1506-1510
[36]朱太咏,宋文昭,马克昌.淫羊藿水煎提取液促进鸡胚背根神经节神经突起生长和DNA、RNA合成的实验研究[J].中医正骨1999,11(9):61-62
[37]牛锐.淫羊藿炮制前后对小鼠血浆睾酮及性器官的影响[J].中国中药学杂志1995;(9):1818-1819
[38]熊跃斌,周楚华.淫羊藿和菟丝子提取物对雄性生殖功能的影响[J].中国药学杂志1994;29(2):89-90
[39]徐瑶,卞国武,吴敏毓.淫羊藿醇提物对内皮细胞释放NO的影响[J].中药新药与临床药理2001,12(1):38-64
[40]曾炎辉.淫羊藿治疗绝经后骨质疏松症50例[J].陕西中医2005,26(5):405-406
[41]赵丽娜.淫羊藿防治骨质疏松临床效果评价[J].现代中西医结合杂志2003,12(9):922-923
[42]李青南,吴铁,谢华.淫羊藿提取液对去睾丸大鼠骨代谢的影响[J].中草药1993,24(12):637-640
[43]李青南,廖进民,吴铁,黄莲芳.淫羊藿预防羟基脲致雄大鼠骨质疏松的定量研究[J].中国中医骨伤科杂志1996,4(3):1-4
[44]解芳,张岩,吴春福,姚新生,黄文秀.淫羊藿提取物对去卵巢大鼠骨转换率增强的抑制作用[J].中草药2005,36(11):1667-1669
[45]叶纯,苏进,王凡.淫羊藿水提液对去势大鼠松质骨的影响[J].中国临床解剖学杂志2008,26(1):87-90
[46]叶纯,苏进,王凡.淫羊藿影响去势大鼠椎骨微环境中TNF-α、TGF-β1表达的研究[J].中国临床解剖学杂志2006,24(6):687-690
[47]刘道德,王凡,李健,李宁,叶纯.淫羊藿对家兔骨折愈合影响的实验研究[J].四川解剖学杂志2004,12(2):101-105
[48]赵凯,徐胜春.淫羊藿对大鼠退变颈椎骨组织钙、磷代谢的影响[J].安徽中医学院学报2008,27(2):24-26
[49]赵凯,徐胜春,吴建贤,王斌,梁维龙.淫羊蓿对大鼠退变颈椎间盘内IL-1β、IL-6、 TNF-α含量的影响[J].安徽医科大学学报2008,43(3):298-301
[50]洪定钢,时光达.淫羊藿影响骨折愈合的骨组织学及骨组织形态计量学研究[J].中医正骨1999,11(2):3-6
[51]李健,叶纯,刘道德,王凡.含淫羊藿血清对SD大鼠骨体外生长发育的影响[J].四川解剖学杂志2004,12(2):106-109
[52]李芳芳,宋士军,李建平,李恩.淫羊藿对成骨细胞增殖分化的影响[J].中国骨质疏松杂志,1999,5(2):70-72
[53]马涛,崔燎,吴铁,艾春媚,李青南.老年大鼠含淫羊藿血清对成骨细胞的增殖与分化的影响[J].中国骨质疏松杂志,2002;8(1):55-60
[54]王晶,于世凤,庞淑珍.淫羊藿抑制颌骨骨吸收的体外实验研究[J].中国骨质疏松杂志2004,10(3):277-279
[55]陈坤,于世凤,史凤芹,庞淑珍.黔岭藿对体外培养的破骨细胞作用的研究[J].中国骨质疏松杂志1996,2(3):59-61
[56]郑洪军,吕振华,胡有谷,齐宗华,黄公怡.淫羊藿对体外培养破骨细胞的影响[J].中华实验外科杂志2009,17(5):460-461
[57]李晶晶,于世凤,李铁军,庞淑珍.淫羊藿对口腔各矿化组织破骨细胞性骨吸收的体外实验研究[J].中华口腔医学杂志2002,37(5):391-393
[58]冯坤,谢文,陈宝龙,王健智,郭建刚.5种淫羊藿对软骨组织生长和软骨细胞增殖影响的对比研究[J].中国中药杂志2006;31(24):2065-2067
[59]吴白燕,邹俊华,孟书聪,郑振.枸杞子、淫羊藿对衰老.年轻2BS融合细胞DNA合成的影响[J].中国中西医结合杂志2003,23(12):926-928
[60]塞冬.淫羊藿、肉苁蓉、巴戟天对果蝇寿命影响的研究[J].老年医学与保健2004,10(3):140-141
[61]包名家,周维民,王建萍,魏晓东.淫羊藿对D-半乳糖诱导的衰老小鼠大脑皮层一氧化氮的影响[J].中国老年学杂志2005,25(2):460-461
[62]王学美,富宏,刘庚信.淫羊藿、枸杞子对老年大鼠线粒体DNA缺失、线粒体呼吸链酶复合体和ATP合成的影响[J].北京大学学报(医学版)2002,34(1):68-71
[63]秦洛宜,桂伟.淫羊藿对糖皮质激素致大白鼠肾上腺损伤的保护作用[J].中医正骨2002,14(11):9-10
[64]吴铁,崔燎,张志平,李青南,廖进民,黄连芳.淫羊藿对抗肾上腺皮质激素不良反应的实验研究[J].中国中药杂志1996,21(12):748-163
[65]杜娟,凌昌全,陈永安.淫羊藿和熟地煎剂对糖皮质激素受体下调模型大鼠糖皮质激素 受体的影响[J].中国中西医结合杂志2008,28(1):64-67
[66]苗起芬,马俐儒,赵春华,胡宇华.淫羊藿对慢性肾盂肾炎患者血清白介素6、白介素8的影响[J].中国老年学杂志2005,25(10):1177-1178
[67]吴东方,马俊玲,周健,罗顺德.淫羊藿提取液对庆大霉素急性肾损伤的影响[J].中国医院药学杂志2002,22(5):270-271
[68]NIKSIC L,MARTIN P Y.BMP-7(Bone morphogenetic protein-7):a future treatment for chronic renal failure[J].Rev Med Suisse Romande 2005,1(8):568-573
[69]周乐,崔燎,吴铁.淫羊藿对肾阳虚雄性大鼠肾脏BMP-7表达的影响[J].广东医学院学报2007,25(4):371-386
[70]周乐,崔燎,吴铁.淫羊藿对肾阳虚雄性大鼠肾脏和股骨BMP-7表达的影响[J].中国骨质疏松杂志2008,14(2):90-94
[71]陈晓蕾,汤立建,李庆林.淫羊藿、秦皮醇提取物体外抗乳腺癌细胞增殖的研究[J].中国药房2007,18(15):1124-1127
[72]郭海萍,刘晓雁,刘鹏熙,陈秀议,韦熹雯.仙茅、淫羊藿颗粒剂对乳腺癌MCF-7细胞增殖的影响[J].中药材2008,31(5):731-733
[73]郭海萍,刘晓雁,刘鹏熙.淫羊藿颗粒剂联合三苯氧胺对乳腺癌MCF-7细胞增殖的调节作用[J].解剖学研究2008,30(3):181-189
[74]聂红明,汪蓉,胡锦辉,姚成增,金树根,王灵台.淫羊藿水煎液和淫羊藿甙的保肝利胆实验研究[J].实用中医内科杂志2006,20(4):370-372
[75]詹继红,吴晓勇.单味淫羊藿对再生障碍性贫血大鼠细胞因子的影响[J].辽宁中医药大学学报2008,10(3):120-121
[76]谢瑾玉,董竞成,崔众,黄建华,巫善美,陈伟华,应健.淫羊藿对哮喘大鼠肺组织RANTES及MCP-3表达的影响[J].中国中西医结合杂志2008,28(3):238-241
[77]吕莹,牛英鹏,曲天敏.淫羊藿对运动员血糖、血乳酸、血液尿素氮等指标影响的实验研究[J].河南师范大学学报(自然科学版)2000,28(3):93-95
[78]李朝阳,石进校,粟银,唐伟.箭叶淫羊藿叶醇提物对自由基的清除作用[J].华中科技大学学报(自然科学版)2003,31(9):105-107
[79]牛英鹏,吕莹,曲天敏,乔风杰,杨中汉.淫羊藿对羟基自由基的清除作用[J].中国运动医学杂志2000,19(4):434-435
[80]国家药典委员会.中国药典[M].第一部.北京:化学工业出版社2000:267-268
[81]关利新,衣欣,杨履艳,吕怡芳.淫羊藿甙扩血管作用机制的研究[J].中国药理学通报1996,12(4):320-322
[82]潘志伟,王秋娟,徐静,杜保生,孔令义.淫羊藿苷对大鼠离体心脏的作用及对血液流变学的影响[J].中国药科大学学报2007,38(5):429-432
[83]潘志伟,王秋娟,杨涓,孔令义,王蓓.淫羊藿苷对异丙肾上腺素致大鼠急性心肌缺血的影响[J].中国药理学通报2007,23(5):622-625
[84]王英军,孙英莲,唐炜,徐宏,许荔新.淫羊藿总苷对实验动物心血管系统的影响[J].中草药2007,38(1):97-99
[85]Danyan Zhu,Linhai Qu,Xiangnan Zhang,Yijia Lou.Icariin-mediated modulation of cell cycle and p53 during cardiomyocyte differentiation in embryonic stem cells.European Journal of Pharmacology 2005(514):99-110
[86]汪晶晶,唐其柱,王腾,刘淼,王小玲.淫羊藿苷对兔心室肌细胞L-型钙电流的影响[J].武汉大学学报(医学版)2007,28(3):282-286
[87]潘志伟,王秋娟,柳仁民,孔令义.淫羊藿苷预适应对乳鼠心肌细胞的保护作用[J].中国药科大学学报2007,38(1):73-76
[88]刘桦,季晖,张超英.淫羊藿苷对异丙肾上腺素所致乳鼠心肌细胞损伤的保护作用[J].中国药理学通报2006,22(12):1509-1512
[89]Qiu-Juan Wang,Zhi-Wei Pan,YuWang,Juan Yang,Ying Jia and Ling-Yi Kong.Protective effects of icariin on human umbilical vein endothelial cell injured by angiotensin Ⅱ[J].Journal of Chinese Pharmaceutical Sciences 2008,17:16-21
[90]王茜,林焕冰,程玉芳,徐江平.淫羊藿苷对高脂血症大鼠粘附分子基因表达的影响[J].中国动脉硬化杂志2008,16(1):4-6
[91]王敏,刘崇铭,张宝风.淫羊藿苷扩张脑血管作用的研究[J].沈阳药学院学报1992,8(4):272-274
[92]李梨,周岐新,杨俊卿,石京山.淫羊藿甙对脑缺血再灌损伤小鼠的保护作用[J].四川生理科学杂志2004,26(4):173-175
[93]李梨,吴芹,周岐新,石京山.淫羊藿苷对氧自由基所致大鼠脑线粒体损伤的保护作用[J].中国药理学与毒理学杂志2005,19(5):333-337
[94]Lin Wang,Ling Zhang,Zhi-Bin Chen,Jia-Yong Wu,Xin Zhang,Yun Xu.lcariin enhances neuronal survival after oxygen and glucose deprivation by increasing SIRTI.European Journal of Pharmacology 2009(待发)
[95]肖幸丰,郑明,瞿林海,张幸国,楼宜嘉.淫羊藿苷伍用三七总皂苷对Aβ-淀粉肽25-35侧脑室注射所致大鼠行为异常及脑组织AchE活性的影响[J].中国现代应用药学杂志2005,22(3):178-181
[96]徐瑞霞,吴芹,龚其海,罗璨,石京山.淫羊藿苷防治血管性痴呆的实验研究[J].四川 生理科学杂志2004,26(4):174-175
[97]罗勇,聂晶,龚其海,陆远富,吴芹,石京山.淫羊藿苷对三氯化铝诱导痴呆大鼠模型脑内胆碱能系统的影响[J].上海中医药杂志2008,42(4):69-72
[98]罗勇,聂晶,龚其海,陆远富,吴芹,石京山.淫羊藿苷减轻铝诱导的大鼠学习记忆减退并增强皮质及海马Na~+-K~+-ATPase、Ca~(2+)-ATPase活性[J].中药药理与临床2008,24(3):24-25
[99]聂晶,罗勇,黄燮南,陆远富,孙安盛,龚其海,石京山.淫羊藿苷对淀粉样β蛋白片段25-35所致大鼠学习记忆障碍的改善作用[J].中国药理学与毒理学杂志2008,22(1):31-37
[100]王俊勤,胡有谷,郑洪军,齐宗华.淫羊藿甙对体外培养成骨细胞增殖和分化的影响[J].中国临床康复2002,6(9):1307-1308
[101]殷晓雪,陈仲强,党耕町.葛根素和淫羊藿甙对成骨细胞生物学作用的比较研究[J].中国骨与关节损伤杂志2007,22(3):210-212
[102]Jiyuan Zhao,Shinsuke Ohba,Masashige Shinkai,Ung-il Chung,Teruyuki Nagamune.Icariin induces osteogenic dierentiation invitro in a BMP- and Runx2-dependent manner.Biochemical and Biophysical Research Communications 2008(369):444-448
[103]胡云峰,侯加法,邓益锋,周振雷,姚静.淫羊藿苷对鸡胚成骨细胞增殖和分化的影响[J].中国农学通报2007,23(3):43-46
[104]李淑梅,宋利格,张秀珍.淫羊藿甙对大鼠成骨细胞功能及Osterix表达的影响[J].同济大学学报(医学版)2005,26(6):8-11
[105]于波,杨久山,刘岩,董建文.淫羊藿苷对人成骨细胞的作用[J].中医正骨2006,18(6):17-18
[106]张立娟,雷涛,张秀珍.淫羊藿甙对成骨细胞凋亡的影响[J].同济大学学报(医学版)2008,29(1):30-33
[107]刘素彩,孔德娟,赵京山,李恩.淫羊藿甙对大鼠成骨细胞增殖与分化的影响[J].中国中医基础医学杂志2001,7(8):28-30
[108]陈虹,张秀珍.淫羊藿甙对大鼠成骨细胞分泌细胞因子的影响[J].同济大学学报(医学版)2005,26(2):5-16
[109]雪原,王沛,齐清会,倪虹,马信龙,郭世绂.淫羊藿甙对成骨细胞smad4 mRNA作用的实验研究[J].中华骨科杂志2005,25(2):119-123
[110]吕明波,刘兴炎,葛宝丰,陈克明,白孟海,汪玉海,顾九君,马丽萍.淫羊藿苷对破骨细胞活性的影响[J].中国骨伤2007,20(8):529-531
[111]吕明波,刘兴炎,葛宝丰,陈克明,白孟海.淫羊藿苷对小鼠骨髓源性破骨细胞诱导生成及骨吸收功能的影响[J].中国骨质疏松杂志2007,13(5):315-317
[112]黄健,张金超,张天蓝,许善锦,王夔.淫羊藿苷对破骨细胞骨吸收功能的影响及其作用机制[J].科学通报2006,51(24):2851-2856
[113]刘海江,王小平,林娟,余优成,蒋欣泉,张秀丽,周曾同,张卫东.淫羊藿苷和黄芪苷Ⅰ对骨髓基质细胞增殖及成骨能力的影响[J].中药材2006,29(10):1062-1065
[114]陈克明,葛宝丰,马慧萍,刘兴炎,白孟海,马丽萍,吕明波.淫羊藿苷对体外培养骨髓基质干细胞成骨性分化的影响[J].中国骨质疏松杂志2008,14(9):642-645
[115]谢玲玲,邹移海,刘炫斯.淫羊藿苷对骨髓间质干细胞增殖及分泌血管内皮生长因子、碱性成纤维生长因子的影响[J].实用医学杂志2008,24(6):908-910
[116]葛林阜,董政军,姜国胜.淫羊藿苷对小鼠免疫调节作用的研究[J].中华实用医学2001,3(3):25-27
[117]滕菲,曾耀英,黄秀艳,杨志,姚满林,宋兵,李林.淫羊藿甙对小鼠腹腔巨噬细胞体外增殖、吞噬和产生NO的影响[J].2008,28(5):372-375
[118]罗昭华,唐彦萍,袁谨,徐红.淫羊藿甙对巨噬细胞iNOS和TNF-ctmRNA的影响[J].遵义医学院学报2005,28(5):409-411
[119]李书桐,李铁军,郑钦岳,王洪斌.淫羊藿甙对小鼠腹腔巨噬细胞功能的影响[J].第三军医大学学报1996,16(6):541-543
[120]毕可红,张玉昆,葛林阜,董政军,唐天华,任海全,黄宁,姜国胜.淫羊藿苷对受照小鼠免疫与造血功能的影响[J].中国辐射卫生2001,10(6):104-105
[121]李晓冰,金东庆,郭良君,唐天华,张玉昆,任海泉,葛林阜.淫羊藿苷在辐射小鼠免疫学功能恢复中作用的研究[J].中国辐射卫生2002,11(3):171-173
[122]王天然,邢善田,周金黄.淫羊藿苷促进抗体生成的作用[J].药学通报,1987,9:533-535
[123]李书桐,李铁军,郑钦岳.王洪斌.淫羊藿苷对小鼠体外脾脏细胞增殖及产生集落刺激因子样活性的影响[J].第二军医大学学报1995,16(4):340-342
[124]肖幸丰,王志强,楼宜嘉.淫羊藿苷伍用三七总皂苷对小鼠免疫功能的调节作用[J].中草药2006,37(6):888-891
[125]赵勇,张玲,王芸,毛海婷,崔正言.淫羊藿苷的体外免疫调节作用研究[J].中草药1996,27(11):669-673
[126]曹颖瑛,郑钦岳,张国庆,曹尉尉.淫羊藿苷促进小鼠脾细胞IL-3mRNA及IL-6mRNA 的表达[J].第二军医大学学报1998,19(2):199-200
[127]Liu TH,Wang BX,Wang Y.Effect of icariin and its metabolites on the production of cytokines by THP-lcells[J].Acta Pharmaceutica Sinica 2000,35(4):245-249
[128]李晓燕,张玲,王芸,毛海婷,刘炬,温培娥.淫羊藿苷逆转转化生长因子对LAK、CD3AK细胞的免疫抑制作用[J].中国免疫学杂志2000,16(5):266-270
[129]赵勇,张玲,崔止言.淫羊藿苷对HL-60细胞增殖与分化的影响[J].中国药理学通报1996,12(1):52-54
[130]赵勇,崔正言,张玲,李淑贞.MTT法检测淫羊藿甙对几种瘤细胞株增殖的抑制作用[J].上海免疫学杂志1995,15(3):167-168
[131]葛林阜,董政军,姜国胜.淫羊藿苷对急性早幼粒白血病细胞端粒酶活性的影响[J].中国肿瘤生物治疗杂志2002,9(1):36-38
[132]张玲,王芸,毛海婷,温培娥,崔树龄,李晓冰.淫羊藿苷抑制肿瘤细胞端粒酶活性及其调节机制的研究[J].中国免疫学杂志2002,18(3):191-196
[133]李贵新,张玲,王芸.淫羊藿苷诱导肿瘤细胞凋亡及其机制的研究[J].中国肿瘤生物治疗杂志1999,6(2):131-135
[134]李贵新,张玲,王芸,毛海婷,郭鸣.淫羊藿甙诱导白血病细胞凋亡及其对癌基因表达的影响[J].中华血液学杂志2002,23(6):322-323
[135]王伟,张涛,赵明镜.5种中药黄酮对血管平滑肌细胞凋亡的交互作用[J].北京中医药大学学报2000,23(4):18-20
[136]阂红波,王建文,孙继虎,黄勤,步世忠.淫羊霍甙诱导视网膜母细胞瘤细胞凋亡及对Bcl-2的影响.中国中西医结合杂志2003,23(6)基础理论研究特集:147-149
[137]王谦,张玲,毛海婷,顾洪涛,温培娥,李翠玲,杨尚军,夏武青.中药淫羊藿苷逆转肝癌HepG2.2.15细胞恶性表型及诱导分化研究[J].世界华人消化杂志2007,15(19):2087-2092
[138]李翠玲,张玲,顾洪涛,王军,毛海婷,杨尚军,温培娥.淫羊藿苷体内抑瘤作用及其机制[J].中国肿瘤生物治疗杂志2007.114(2):137-142
[139]毛海婷,张玲,王芸.Ica和PJA对高转移性人肺癌细胞体外侵袭转移能力抑制的研究[J].中国免疫学杂志2001,17(1):27-29
[140]毛海婷,张玲,王芸.淫羊藿甙和济南假单胞菌制剂调控PG细胞转移相关基因的表达[J].肿瘤2000,20(1):13-15
[141]毛海婷,张玲,王芸,李晓冰.淫羊藿苷及济南假单胞菌制剂联合应用体外抗转移的研究[J].中国药理学通报2000,16(5):534-537
[142]毛海婷,张玲,王芸,温培峨,崔树龄.淫羊藿甙对人高转移肺癌细胞膜的影响[J].中药材1999,19(1):35-36
[143]唐菁,张玲,顾洪涛,李翠玲,毛海婷,杨尚军,温培娥,阴海鹏.淫羊藿苷、黄芩苷联合多柔比星抑制肝癌细胞APRIL表达和逆转肿瘤免疫逃逸[J].中国肿瘤生物治疗杂志2007,14(6):516-521
[144]张京伟,周云峰,文显梅,魏蕾,杨国梁.淫羊藿甙逆转胃癌细胞恶性表型的研究[J].中华实验外科杂志2006,23(10):1213-1214
[145]李晓燕,张玲,王芸.淫羊藿甙逆转转化生长因子β_2免疫抑制作用的抗肿瘤研究[J].中国肿瘤生物治疗杂志2000,7(2):127-130
[146]王大光,朱文元,马慧军.淫羊藿苷等6种中药单体抑制Cloudman S91黑素瘤细胞株黑素合成的研究[J].临床皮肤科杂志2004,33(4):202-205
[147]李芳芳,李思,吕占军.淫羊藿苷对大鼠卵泡颗粒细胞和肾上腺皮质细胞分泌功能的影响[J].中国中药杂志1997,22(8):499-451
[148]秦路平,石汉平,郑水庆.Osthol和Icariin对甲减小鼠血清甲状腺激素的影响[J].第二军医大学学报1998,19(1):48-52
[149]钟瑜,李晓清,徐晓玉,陈琳,杨国汉.淫羊藿苷对肾阳虚细胞糖皮质激素受体表达影响的研究[J].中国药房2007,18(36):2801-2803
[150]李波,安睿,王新宏.淫羊藿苷和补肾复方对肾阳虚大鼠下丘脑CRH基因和垂体POMC基因表达的影响[J].中成药2008,30(1):132-134
[151]付杰,乔梁,金泰乙,林桂亭,王银叶,辛钟成.淫羊藿苷对家兔阴茎海绵体cGMP浓度的效果[J].中国药理学通报2002,18(4):430-433
[152]蒋兆健,胡本容,付琴,汤强,向继洲,刘菊妍.淫羊藿苷对家兔阴茎海绵体环核苷酸水平的影响[J].华中科技大学学报(医学版)2007,36(2):166-168
[153]田龙,辛钟成,刘武江,袁亦铭,刘刚,陈亮,付杰,王玲珑.淫羊藿苷对动脉性ED模型大鼠阴茎海绵体压力和一氧化氮合酶亚型表达的影响[J].中华医学杂志2004,84(11):954-957
[154]章振保,杨庆涛,杨镜秋,郑俊鸿,周德荣.淫羊藿甙、菟丝子提取物对雄激素部分缺乏大鼠生殖保护作用的比较研究[J].中国老年学杂志2006,26(10):1389-1391
[155]章振保,田生平,杨镜秋,蔡崇岳.淫羊藿与睾酮治疗亚急性衰老雄性大鼠的实验研究[J].中国男科学杂志2006,20(8):13-17
[156]杨春,辛钟成,付杰,袁亦铭,丁义,辛华,汪泽厚.淫羊藿苷对兔阴蒂海绵体平滑肌细胞NO及NOS活性的影响[J].中国男科学杂志2005,19(1):5-10
[157]黄菊,罗丽莉,傅玉才,钱元恕,许锦阶.淫羊藿甙对大鼠早期卵巢卵泡发育和卵母细胞凋亡影响的初步研究[J].中国现代医学杂志2007,17(5):523-527
[158]Kuroda M,Mimaki Y,Sashida Y,Umegaki E,Yamazaki M,Chiba K,Mohri T,Kitahara M,Yasuda A,Naoi N,Xu ZW,Li MR.Flavonol glycosides from Epimedium sagittatum and their neurite outgrowth activity on PC12h cells[J].Planta Medica 2000,66(6):575-577
[159]Lee MK,Choi Y J,Sung SH,Shin DI,Kim JW,Kim YC.Antihepatotoxic activity of icariin,a major constituent of Epimedium koreanum[J].Planta Medica 1995;61(6):523-526
[160]Zhang Y W,Morita 1,Shao G,Yao X S,Murota S.Screening of anti-hypoxia/reoxygenation agents by an in vitro model.Part 1:Natural inhibitors for protein tyrosine kinase activated by hypoxia/reoxygenation in cultured human umbilical vein endothelial cells[J],Planta Medica 2000,66(2),114-118
[161]王国芳,吴织芬,万玲,王勤涛.淫羊藿苷对人牙周膜细胞增殖和骨保护素mRNA表达的影响[J].牙体牙髓牙周病学杂志2006,16(4):223-225
[162]张奉学,张俊丽,符林春,邓文娣,吴爱武,王新华.淫羊藿苷体外抑制SIV感染诱导的CEMx174细胞凋亡[J].中国药理学通报2008,24(5):684-687
[163]徐文,张亚萍,张卫东,张新民,沈自尹.离体大鼠肠道菌群对淫羊藿苷的代谢研究[J].2006,8(6):98-100
[164]MIKSICEK R J.Estrogenic flavonoids:structural requirements for biological activity[J].Proc Soc Exp Biol Meal 1995,208(1):44-50.
[165]Kelly GE,Nelson C,Waring MA,Joannou GE.Metabolites of dietary(soya) isoflavones in humans urine[J].International Journal of Clinical Chemistry 1993,223(1-2):9-22.
[166]赵艳红,贾晓斌,陈彦,范晨怡,Ming Hu.淫羊藿黄酮类化合物的大鼠在体肠吸收研究[J].中国药学杂志2008,43(3):188-191
[167]邱峰,陈英杰,鹿野美弘,姚新生.淫羊藿苷在大鼠体内的代谢[J].药学学报Acta Pharmaceutica Sinica 1999,34(3):222-226
[168]刘铁汉,王毅,王本祥.淫羊藿苷的肠菌代谢研究Ⅰ.肠内细菌对淫羊藿苷的代谢转化[J].中草药2000,31(11):834-837
[169]徐金丽,姜晓野,鱼红闪,安东善,柳青梅,任皖泽,金凤燮.水解淫羊藿苷糖基的土壤细菌筛选[J].大连轻工业学院学报2007,26(4):303-305
[170]刘铁汉,王本祥,王毅,吴立军,南陆彦,永田年,池岛乔.淫羊藿苷及其肠菌代谢产物对THP-1细胞分泌细胞因子的影响[J].Acta Pharmaceutica Sinica 2000,35(4):245-248
[171]LIU Jian,YE Hai-yong,LOU Yi-jia.Determination of rat urinary metabolites of icariin in vivo and estrogenic activities of its metabolites on MCF-7 cells[J].Die Pharmazie,2005,2005,60(2):120-125
[172]叶海涌,刘健,楼宜嘉.淫羊藿苷衍生物的制备及其雌激素样作用研究[J].浙江大学学 报(医学版)2005,34(2):131-136
[173]张翔南,王欢欢,王志强,吴佳莹,朱丹雁,楼宜嘉.淫羊藿素抗Aβ肽致大鼠原代培养神经细胞凋亡作用[J].浙江大学学报(医学版)2007,36(3):223-228
[174]朱丹雁,张翔南,杜悦,陈燕,王忐强,楼宜嘉.淫羊藿素诱导小鼠胚胎干细胞体外定向分化为神经细胞[J].浙江大学学报(医学版)2007,36(3):218-223
[175]张天蓝,黄健,许善锦,王夔.淫羊藿黄酮苷及其代谢产物调控骨代谢的体外实验研究[J].首都医科大学学报2005,26(1):37-38
[176]Jian Huang,LanYuan,Xi Wang,Tian-Lan Zhang,Kui Wang.Icaritin and its glycosides enhance osteoblastic,but suppress osteoclastic,differentiation and activity in vitro[J].Life Sciences 2007,(81)832-840
[177]Yang Li,Zhang Rong-hua(张荣华),Zhu Xiao-feng.Effects ofbenefiting-bone capsule on expression of bone morphogenetic protein-2 in bone tissue 0f the ovariectomized rats[J].Chinese Journal of Clinical Rehabilitation 2006,10(3):190-192
[178]廖清船,肖洲生,秦艳芳,刘亭,赵彦,周宏灏.植物雌激素金雀异黄酮通过p38MAPK 通路促进骨髓间充质干细胞向成骨细胞分化[J].中国药理学通报2006,22(6):683-687
[179]Po-Lin Kuo,Ya-Ling Hsu,Cheng-Hsiung Chang,and Jiunn-Kae Chang.Osthole-Mediated Cell Differentiation through Bone Morphogenetic Protein-2/p38 and Extracellular Signal-Regulated Kinase 1/2 Pathway in Human Osteoblast Cells[J].Journal of Pharmacology And Experimental Therapeutics 2005,18(10):1290-1299
[180]Si-Yuan Tang,Hui Xie,Ling-Qing Yuan,Xiang-Hang Luo,Jiao Huang,Rong-Rong Cui,Hou-De Zhou,Xian-Ping Wu,Er-Yuan Liao.Apelin stimulates proliferation and suppresses apoptosis of mouse osteoblastic cell line MC3T3-E1 via JNKand Pl3oK/Akt signaling pathways[J].Peptides 2007,(28):708-718
[181]Ji-Cheon Jeong,Jae-Wook Lee,Cheol-Ho Yoon,Hyung-Min Kim,CheorI-Ho Kim.Drynariae Rhizoma promotes osteoblast dierentiation and mineralization in MC3T3-E1 cells through regulation of bone morphogeneticprotein-2,alkalinephosphatase,type Ⅰ collagen and collagenase-1[J].Toxicology in Vitro 2004,(18):829-834
[182]程宝莺主编.动物细胞培养技术[M].广州:华南理工大学出版社.2001年第一版:80-132
[183]Chih-Hsin Tang,Rong-Sen Yang,Mei-Yin Chien,Chien-Chich Chen and Wen-Mei Fu.Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts[J].European Journal of Pharmacology 2008,579(28):40-49
[184]Bruder SP,Jaiswal N,Ricalton NS,Mosca JD,Kraus KH,Kadiyala S.Mesenchymal stem cells in osteobiology and applied bone regeneration[J].Clinical Orthopaedics And Related Research 1998,355(3):247-256.
[185]Sierra RI,Specker BL,Jim(?)nez F,Cruz C,Pedraza-Chaverr(?) J.Biochmical bone markers,bone mineral content,and bone mineral density in rats with experimental nephrotic syndrome[J].Renal Failure,1997;19(3):409-424
[186]By Kihara T,Oshima A,Hirose M,Ohgushi H.Tree-dimensional visualization analysis of in vitro cultured bone fabricated by rat marrow mesenchymai stem cells[J].Biochemical and Biophysical Research Communications 2004,316:943-948
[187]Abdallah BM,Jensen CH,Gutierrez GI.Regulation of human skeletal stem celils diferentiation by Dlkl/Pref-1[J].J Bone Miner Res 2004,19(5):841-852.
[188]Sammons J,Ahmed N.The role of BMP-6,IL-6,and BMP-4 in mesenchymal stem cell-dependent bone development:effects on osteoblastic differentiation induced by parathyroid hormone and vitaminD(3)[J].Stem Cells,2004;13(3):273-280
[189]高莉莉,任宪辉,富宏然.骨源性碱性磷酸酶在骨代谢疾病诊断中的应用[J].牡丹江医学院学报2009,30(1):50-51
[190]李德华,刘宝林,吴军正,陈建元.体外培养的成骨细胞中碱性磷酸酶活性的检测方法探讨[J].实用口腔医学杂志1997,13(1):21-22
[191]柯青,刘海全,牛维.补肾方药对绝经后骨质疏松症患者骨密度及血钙、血清碱性磷酸酶的影响[J].中国临床康复2005,9(31):186-189
[192]邢国胜,谈志龙,王淑云,白人骁,沈启捷,禹军.补肾健骨汤对成骨细胞增殖及碱性磷酸酶、骨钙素合成的影响[J].2001,32(11):1020-1022
[193]邵培.桂皮醛对成骨细胞的增殖及其碱性磷酸酶活性的影响.四川大学华西口腔医学院硕士学位论文2007,5:16-25
[194]侯玉.p物质和降钙素基因相关肤对成骨细胞的增殖和碱性磷酸酶活性的影响.第四军医大学硕士学位论文2006,5:21-32
[195]Xu Q,Tian XX.The research on the differentiative produce and the biochemistry standard of osteoblast[J].Clinical Foucus,2003;18(1):55-60
[196]Heino T J,Hentunen TA,Vaananen HK.Conditioned medium from osteocytes stimulates the proliferation of bone marrow mesenchymal stem cells and their differentiation into osteoblasts[J].Experimental Cell Research 2004,294:458-466
[197]徐青,田小秀.成骨细胞分化产物及其生化标准研究进展[J].临床荟萃,2003:18(1):55-56
[198]Collal-driven transgenic markers of osteoblast lineage progression.Collal-driven transgenic markers of osteoblast lineage progression[J].J Bone Miner Res,2001;16(7):1228-1236
[199]Bodine PV,Komm BS.Evidence that conditionally immortalized human osteoblasts express ano steocalcin receptor[J].Bone,1999,25:535-543
[200]Jurutka PW,MacDonald PN,Nakajima S.Isolation ofbaculovirus expressed human vitamin D receptor:DNA responsive element interactions and phosphorylation of the purified receptor[J].J Cell Biochem,2002,85:435-457
[201]刘梅沽,吕国红,邹军,于智敏,王燕平,赵宏艳,鞠大宏.左归丸含药血清对成骨细胞分泌骨钙素的影响[J].中国中医基础医学杂志2007,13(8):581-582
[202]王建华,李力更,冯风莲.染料木素对大鼠成骨细胞骨钙素表达的影响[J].中药药理与临床2004;20(5):10-11
[203]Oxlund H,Mosekilde L,Ouoft G.Reduced concentration of collagen reducible cross links in human trabecullar bone with respect to age and osteoporosis[J].Bone 1996,19:479-484.
[204]Hosoi T.Bone and bone related biochemical examinations Bone and colagen related metabolites Structure and metabolisms of collagen[J].Clin Calcium,2006,16(6):971-980
[205]Charles P,Mosekilde L,Risteli L,Risteli J,Eriksen EF.Assessment of bone remodeling using biochemical indicators of type Ⅰcollagen synthesis and degredation:relation to calcium kinetics[J].Bone And Mineral 1994,(24):81-94
[206]Wenstrup RJ,Witte DP,Florer JB.Abnormal differentiation in MC3T3-E1 preosteoblasts expressing a dominant-negative type Ⅰcollagen mutation[J].Connective Tissue Research 1996,35(1-4):249-257
[207]Garnero P,Somay-Rendu E,Chapuy MC,Delmas PD.Increased bone tumover in late postmenopausal women is a major determinant of osteoporosis[J].J Bone Miner Res 1996,(11):337-349
[208]Hosoi T.Bone and bone related biochemical examinations Bone and colagen related metabolites Structure and metabolisms of collagen[J].Clin Calcium 2006;16(6):971-980
[209]Stein GS,Lian JB,Stein JL,Van Wijnen A J,Montecino M.Transcriptional control of osteoblast growth and differentiation[J].Physiological reviews 1996,76:593-599
[210]Galvin RJ,Cullison JW,Avioli LV.Influence of osteoclasts and osteoclast-like cells on osteoblast alkaline phosphatase activity and collagen synthesis[J].J Bone Miner Res 1994,9(8):1167-1178
[211]Chen TL,Bates RL.Recombinant human transforming growth factor beta 1 modulates bone remodeling in a mineralizing bone organ culture[J].J Bone Miner Res 1993,8(4):423-434
[212]徐传毅,何伟,方斌,樊粤光,袁浩.生脉成骨方对股骨头坏死Ⅰ型胶原表达的调节作用研究[J].现代中西医结合杂志2003,12(6):574-576
[213]常红,黄国伟,刘莉,任大琳,王媛.染料木黄酮对成骨细胞Ⅰ型胶原表达及转化生长因子β1的影响[J].Aeta Nutrimenta Sinica 2008,30(2):194-198
[214]Prouillet C,Mazi(?)re JC,Mazi(?)re C,Wattel A,Brazier M,Kamel S.Stimulatory effect of naturally occurring flavonols quercetin and kaempferol on alkaline phosphatase activity in MG-63 human osteoblasts through ERK and estrogen receptor pathway[J].Biochem Pharmacol.2004,67(7):1307-1313
[215]Shang Y,Hu X,DiRenzo J,Lazar MA,Brown M.Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription.Cell 2000,103 (6):843-852
[216]Smith CL.Cross-talk between peptide growth factor and estrogen receptor signaling pathways[J].Biology Of Reproduction 1998,58(3):627-632
[217]Ueda S,Tsuda H,Sato K,Takeuchi H,Shigekawa T,Matsubara O,Hiraide H,Mochizuki H.Alternative tyrosine phosphorylation of signaling kinases according to hormone receptor status in breast cancer overexpressing the insulin-like growth factor receptor type 1[J].Cancer Science 2006,97(7):597-604
[218]Lannigan DA.Estrogen receptor phosphorylation^].Steroids 2003,68(1):1-9
[219]Tremblay A,Giguere V.Contribution of steroid receptor coacti vator-1 and CREB binding protein in ligand-independent activity of estrogen receptor beta[J].J Steroid Biochem Mol Biol 2001,(77):19-27
[220]Paech K,Webb P,Kuiper GG,et al.Differential ligand activation of estrogen receptors ERaand ERpat AP1 sites[J].Science 1997,277 (5331):1508-1510
[221]PappasT C,Gametchu B,W atson C S.Membrane estrogen receptors identified by multiple antibody labeling and impededligand binding[J].The FASEB Journal 1995,9(5):404-410
[222]Razandi M,Pedram A,Greene GL,Levin ER.Cell membrane and nuclear estrogen receptors(ERs)originate from a single transcript:studies of Era and Erp expressed in Chinese hamster ovary cells[J].Molecular Endocrinology 1999,13(2):307-319
[223]Hisamoto K,Bender JR.Vascular cell signaling by membrane estrogen receptors[J].Steroids 2005,70 (5-7):382-387
[224]Morey AK,Razandi M,Pedram A,Hu RM,Prins BA,Levin ER.Oestrogen and progesterone inhibit the stimulated production of endothelin-l[J].The Biochemical Journal 1998,330(3):1097-1105
[225]Kousteni S,Bellido T,Plotkin LI,O'Brien CA,Bodenner DL,Han L,Han K,DiGregorio GB,Katzenellenbogen JA,Katzenellenbogen BS,Roberson PK,Weinstein RS,Jilka RL,Manolagas SC.Nongenotropic,sex-nonspecific signaling through the estrogen or androgen receptors:dissociation from transcriptional activity[J].Cell 2001,(104):719-730
[226]Howell A,Osborne CK,Morris C,Wakeling AE.ICI 182,780 (Faslodex):development of a novel,"pure" antiestrogen [J].Cancer 2000,89(4):817-825
[227]孟庆书,何平,朱晓燕,倪鑫．植物雌激素的作用机制[J]．生命的化学2007,27(2)：142-143
[228]Johnson GL,Lapadat R.Mitogen-activated protein kinase pathways mediated by ERK,JNK, and p38 protein kinases[J].Science 2002,298(5600):1911-1912
[229]Chang L,Karin M.Mammal inaMAP kinase signaling cascades[J].Nature 2001,410:37-40.
[230]Jaiswal RK,Jaiswal N,Bruder SP,Mbalaviele G,Marshak DR,Pittenger MF.Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase[J].The Journal Of Biological Chemistry 2000,275(73):9645-9652
[231]Oyama M,Chiba J,Kato Y,lgarashi N,Yoshida M,lshigami M,Sugawara S,Kobayashi M.Distribution and expression of mRNAs for the proto-oncogenes c-fos and c-jun in bone cells in vivo[J].Histology And Histopathology 1998,13(3):671-678
[232]Suzawa M,Takada I,Yanagisawa J,Ohtake F,Ogawa S,Yamauchi T,Kadowaki T,Takeuchi Y,Shibuya H,Gotoh Y,Matsumoto K,Kato S.Cytokines suppress adipogenesis and PPAR-gamma function through the TAK1/TAB1/NIK cascade[J].Nature Cell Biology 2003,5(3):224-230
[233]Suzuki A,Guicheux J,Palmer G,Miura Y,Oiso Y,Bonjour JP,Caverzasio J.Evidence for a role of p38 MAP kinase in expression of alkaline phosphatase during osteoblastic cell differentiation[J].Bone 2002,30(1):91-98
[234]Lee KS,Hong SH,Bae SC.Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein[J].Oncogene 2002,21(47):7156-7163
[235]黄鲁豫,胡蕴玉,明井阳西,川昌孝吉,川秀树,陶惠人.p38丝裂原活化蛋白激酶信号途径在鼠破骨细胞生成和骨吸收中的作用[J].中华风湿病学杂志2006,10(4):202-205
[236]张文军,李荣山.p38丝裂原活化蛋白激酶通路及其研究进展[J].医学综述2007,13(9):663-665
[237]Brewster JL,De Valoir T,Dwyer N,et al.An osmosensing signal transduction pathway in yeast[J].Science 1993,259(5099):1760-1763.
[238]Han J,Lee JD,Bibbs L,Ulevitch RJ,.A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells[J].Science 1994,265(5173):808-811
[239]Raingeaud J,Whitmarsh AJ,Barrett T;D(?)rijard B,Davis RJ.MKK3 and MKK6 regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway[J].Molecular And Cellular Biology 1996,16(3):1247-1255
[240]Obata T,Brown GE,Yaffe MB.MAP kinase pathways activated by stress:the p38MAPK pathway[J].Critical Care Medicine 2000,28(4):67-77
[241]A.Rey,D.Manen,R.Rizzoli,S.L.Ferrari,J.Caverzasio.Evidences for a role of p38MAP kinase in the stimulation of alkaline phosphatase and matrix mineralization induced by parathyroid hormone in osteoblastic cells[J].Bone 2007,(41):59-67
[242]A.Ishisaki,H.Tokuda,M.Yoshida,K.Hirade,K.Kunieda,D.Hatakeyama,T.Shibata,O. Kozawa.Activation of p38 mitogen-activated protein kinase mediates thyroid hormone-stimulated osteocalcin synthesis in osteoblasts[J].Molecular and Cellular Endocrinology 2004,(214):189-195
[243]Kyeong-Sook Lee,Hyun-Jung Kim,Qing-Lin Li,Xin-Zi Chi,Chisato Ueta,Toshihisa Komori,John M.Wozney,Eung-Gook Kim,Je-Young Choi,Hyun-Mo Ryoo,and Suk-Chul Bae.Runx2 ls a Common Target of Transforming Growth Factor β1 and Bone Morphogenetic Protein 2,and Cooperation between Runx2 and Smad5 Induces Osteoblast-Specific Gene Expression in the Pluripotent Mesenchymal Precursor Cell Line C2C12[J].Molecular and Cellular Biology.2000,20(23):8783-8792
[244]Ekaterini Pantouli,Matthew M.Boehm,Sreenivas Koka.Inflammatory cytokines activate p38MAPK to induce osteoprotegerin synthesis by MG-63 cells[J].Biochemical and Biophysical Research Communications 2005(329):224-229
[245]Chiho Minamitani,Takanobu Otsuka,Shinji Takai,Rie Matsushima-Nishiwaki,Seiji Adachi,Yoshiteru Hanai,Jun Mizutani,Haruhiko Tokuda,Osamu Kozawa.Involvement of Rho-kinase in prostaglandin F2α-stimulated interleukin-6 synthesis via p38mitogen-activated protein kinase in osteoblasts[J].Molecular and Cellular Endocrinology 2008,(291):27-32
[246]Xiang-Hang Luo,Li-Juan Guo,Ling-Qing Yuan,Hui Xie,Hou-De Zhou,Xian-Ping Wu,Er-Yuan Liao.Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway[J].Experimental Cell Research 2005(309):99-109
[247]UlrichNoth,Richard Tuli,Reza Seghatoleslami,Michael Howard,Asit Shah,David J.Hall,Noreen J.Hickok,and Rocky S.Tuan.Activation of p38 and Smads mediates BMP-2 effects on human trabecular bone-derived osteoblasts[J].Experimental Cell Research 2003(291):201-211
[248]黄少慧,李娟,赵毅,张娟.补肾中药骨灵片对人成骨细胞功能和p38活化原蛋白激酶通路的影响[J].热带医学杂志2007,7(5):418-425
[249]Chih-Hsin Tang,Rong-Sen Yang,Mei-Yin Chien,Chien-Chich Chen,Wen-Mei Fu.Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts[J].European Journal of Pharmacology 2008(579):40-49
[250]Ya-Ling Hsu,Jiunn-Kae Chang,Chu-Hung Tsai,Tzu-Tsung Chang Chien,Po-Lin Kuo.Myricetin induces human osteoblast differentiation through bone morphogenetic protein-2/p38mitogen-activated protein kinase pathway[J].Biochemical pharmacology 2007,(73):504-514
[251]Masatake Izumi,Masahito Watanabe,Kohei Sawaki,Hideharu Yamaguchi,Mitsuru Kawaguchi.Expression of BMP7 is associated with resistance to diabetic stress: Comparison among mouse salivary glands.European Journal of Pharmacology 2008,596(7):1-5
[252]Termaat MF,Den Boer FC,Bakker FC,Patka P,Haarman HJThM.Bone morphogenetic proteins.Development and clinical efficacy in the treatment of fractures and bone defects [J].The Journal Of Bone And Joint Surgery 2005,87A(6):1367-1378
[253]Groeneveld EH,Burger EH.Bone morphogenetic proteins in human bone regeneration[J].European Journal Of Endocrinology 2000,142(1):9-21.
[254]Shigeyuki Kato,Niki Kawabata,Naoto Suzuki,Masako Ohmura,Minoru Takagi.Bone morphogenetic protein-2 induces the differentiation of a mesenchymal progenitor cell line,ROB-C26,into mature osteoblasts and adipocytes[J].Life Sciences 2009 (84):302-310
[255]Saito T,Ogawa M,Hata Y,Bessho K.Acceleration Effect of Human Recombinant Bone Morphogenetic Protein-2 on Differentiation of Human Pulp Cells Into Odontoblasts[J].Journal Of Endodontics 2004,30 (4):205-208
[256]W.Singhatanadgit,V.Salih,I.Olsen.RNA interference of the BMPR-IB gene blocks BMP-2-induced osteogenic gene expression in human bone cells[J].Cell Biology International 2008,(32):1362-1370
[257]Yamaguchi A,Komori T,Suda T.Regulation of osteoblast differentiation mediated by bone morphogenetic proteins,Hedgehogs and Cbfal[J].Endocrine Reviews 2000,21(4):393-411
[258]Ishida W,Hamamoto T,Kusanagi K,Yagi K,Kawabata M,Takehara K,Sampath TK,Kato M,Miyazono K.Smad6 is a Smad1/5-induced smad inhibitor.Characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter [J].The Journal Of Biological Chemistry 2000,275(9):6075-6079
[259]Chen D,Ji X,Harris MA,Feng JQ,Karsenty G,Celeste AJ,Rosen V,Mundy GR,Harris SE.Differential roles for bone morphogenetic protein (BMP)receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages [J].The Journal Of Cell Biology 1998,142(1):295-305
[260]Cheng H,Jiang W,Phillips FM,Haydon RC,Peng Y,Zhou L,Luu HH,An N,Breyer B,Vanichakarn P,Szatkowski JP,Park JY,He TC.Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs)[J].The Journal Of Bone And Joint Surgery.American Volume 2003,85(8):1544-1552
[261]Onishi T,Ishidou Y,Nagamine T,Yone K,Imamura T,Kato M,Sampath TK,ten Dijke P,Sakou T.Distinct and overlapping patterns of localization of bone morphogenetic protein(BMP)family members and a BMP type Ⅱ receptor during fracture healing in rats[J].Bone 1998,22(6):605-612
[262]Imamura T;Maeda S,Hayashi M.Regulation of BMP signaling[J].Clinical Calcium 2006,16(5):738-744
[263]Petra Simic,Slobodan Vukicevic.Bone morphogenetic proteins:from developmental signals to tissue regeneration.Conference on bone morphogenetic proteins.EMBO reports.2007,8(4):327-331
[264]Fumitaka Kugimiya,FumikoYano,ShinsukeOhba,Kazuyo Igawa,Kozo Nakamura,Hiroshi Kawaguchi,Ung-il Chung.Mechanism of osteogenic induction by FK506 via BMP/Smad pathways[J].Biochemical and Biophysical Research Communications 2005,(338):872-879
[265]Ippei Kanazawa,Torn Yamaguchi,Shozo Yano,Mika Yamauchi,Toshitsugu Sugimoto.Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2 expression[J].Biochemical and Biophysical Research Communications 2008,375(8):414-419
[266]Wei Zhu,Jaehon Kim,Christina Cheng,Bernard A.Rawlins,Oheneba Boachie-Adjei,Ronald G.Crystal,Chisa Hidaka.Noggin regulation of bone morphogenetic protein(BMP)2/7 heterodimer activity invitro[J].Bone 2006,(39):61-69
[2]刘信顺,杨滨.淫羊藿属植物的化学成分[J].中草药1990,21(9):36-39
[3]林新,李文魁,肖培根.淫羊藿的研究新进展[J].中国药学杂志1997,32(8):449-451
[4]刘佳,吴克枫,俞红,李锦兰,阮海星.淫羊藿对小鼠免疫功能的调节作用[J].卫生研究1997,26(6):399-340
[5]程庆,陈香美,师锁柱,于力方.中药淫羊藿对慢性肾衰大鼠免疫病理及细胞外基质的影响[J].中华微生物学和免疫杂志1993,13(3):199-121
[6]孙奕,王景明,骆永珍.淫羊藿对小鼠MPS吞噬功能和红细胞免疫粘附功能的影响及相关性研究[J].中国免疫学杂志2002,(18):114-116
[7]刘佳,吴克枫.淫羊藿煎汁对小鼠免疫功能的影响[J].贵阳医学院学报1996,21(1):18-21
[8]张玲娟,沈自尹,蔡定芳,陈晓红,沈时谋.淫羊藿对大鼠下丘脑-垂体-肾上腺-胸腺轴抑制模型的影响[J].中医杂志1996,37(10):621-623
[9]陆军,崔爱东,蔡良.淫羊藿对血液透析患者T淋巴细胞亚群的影响[J].中西医结合实用临床急救.1998,5(4):148-150
[10]熊平源,郭凯文,唐朝辉,白惠卿.淫羊藿对小鼠免疫功能的调节作用[J].数理医药学杂志2007,20(1):50-52
[11]汪年松,唐令诠,竺艳娟,廖履坦.淫羊藿对血液透析HCV感染者细胞免疫功能的作用[J].上海免疫学杂志2001,21(2):115-116
[12]苗起芬,马俐儒,赵春华,胡宇华.淫羊藿对慢性肾盂肾炎患者血清白介素6、白介素8的影响[J].中国老年学杂志2005,10:1177-1178
[13]陈玉春.补益中药调控IL-2产生及其作用的实验研究.福建中医学院学报1993,3(4):218-221
[14]陈香美,廖洪军,李宁虹,卢英杰.慢性肾衰大鼠IL-2基因表达的改变及淫羊藿的调节作用[J].解放军医学杂志1995,20(5):353-356
[15]廖洪军,陈香美,李文戈,程庆.淫羊藿对血液透析患者生存质量及细胞免疫功能的影响[J].中国中西医结合杂志1995,15(4):202-205
[16]陈香美,周美华,王建中,段永刚.血液透析患者sIL-2R、IL-6变化与淫羊藿的免疫调节作用[J].中华内科杂志1995;34(2):102-104
[17]肖崇厚,孙奕,骆永珍.川产淫羊藿对羟基脲阳虚小鼠IL-2活性的影响[J].中国免疫学杂志1995;11(6):373-376
[18]赵福东,董竞成,崔焱,谢瑾玉,吴金峰,宫兆华,巫善美.淫羊藿对哮喘大鼠神经内分泌免疫网络若干指标的影响[J].中国实验方剂学杂志2007,13(9):44-46
[19]骆永珍,袁必文,姚玉龙,孙奕,沈文龙.“外气”与淫羊藿对“阳虚”小鼠NK细胞活性的影响[J].云南中医学院学报1996,19(3):31-35
[20]陈玮,邹焰,姜东.人参、淫羊藿增强小鼠免疫功能的协同作用[J].遵义医学院学报2001,24(2):124-125
[21]郭英,谢建平,曾博程,莫正纪.淫羊藿提取物对大鼠急性心肌缺血的影响[J].华西药学杂志2005,20(1):44-45
[22]郭英,谢建平,莫正纪.淫羊藿提取物对急性心肌缺血大鼠血流动力学的影响[J].中国医药工业杂志2005,36(5):286-287
[23]张丽君,刘宏权,吕文伟,石毅.淫羊藿提取物对犬急性心肌缺血的保护作用[J].中华老年心脑血管病杂志2006,8(11):765-767
[24]岳攀,王秋娟,胡哲一,孔令义.淫羊藿提取物对犬血流动力学的影响[J].中国天然药物2004,2(3):184-188
[25]杨远友,刘宁,莫正纪,谢建平,廖家莉,莫尚武.淫羊藿对大鼠内脏器官PDC钙通道及其心肌缺血性损伤的影响[J].四川大学学报(自然科学版)2005,42(1):122-127
[26]王少峡,房蓓,张志国.淫羊藿提取物对大鼠胸主动脉Ca2+内流量的影响[J].天津中医学院学报2003,22(2):16-18
[27]于永红,胡昌兴,孟卫星,张国安,王当金.茵陈、赤芍、三棱、淫羊藿对家兔实验性动脉粥样硬化病灶的消退作用及原癌基因C-mye、C-fos、V-sis表达的影响[J].湖北民族学院学报(医学版)2001,18(2):4-6
[28]刘崇铭,王敏,梁利春.淫羊藿黄酮对脑血管与脑缺血的作用[J].沈阳药学院学报1995,12(3):19-23
[29]宫洪涛,郭可红,王宝亮,秦润笋,张振强.淫羊藿注射液穴位注射治疗血管性痴呆60例疗效观察[J].中医杂志2003,44(2):103-104
[30]严金玲,钟有添,曾靖,陈秋英,赖飞,黄贤华.淫羊藿水提取液对小鼠睡眠功能和自发活动的影响[J].中国临床康复2004,8(33):7460-7461
[31]Peng YL,Zhu XY,Xeng J.et al.Effects ofherba epimedium extract om spontaneous activity and sleep function of mice[J].Chinese Journal of Clinical Rehabilitation 2005,9(40):164-166
[32]赖飞,曾靖,黄贤华,叶和扬,朱遵平,杨敬格.淫羊藿水提取液中枢抑制作用的研究 [J].赣南医学院学报2003,23(3):268-270
[33]曾靖,赖飞,叶和杨,黄贤华.淫羊藿水提取液局部麻醉作用的研究[J].赣南医学院学报2004,24(1):1-3
[34]李良东,黄志华,曾靖,周俐,周青.淫羊藿水提取液镇痛作用的研究[J].赣南医学院学报2004,24(1):14-15
[35]钟海波,潘颖,孔令东.淫羊藿提取物抗抑郁作用研究[J].中草药2005,36(10):1506-1510
[36]朱太咏,宋文昭,马克昌.淫羊藿水煎提取液促进鸡胚背根神经节神经突起生长和DNA、RNA合成的实验研究[J].中医正骨1999,11(9):61-62
[37]牛锐.淫羊藿炮制前后对小鼠血浆睾酮及性器官的影响[J].中国中药学杂志1995;(9):1818-1819
[38]熊跃斌,周楚华.淫羊藿和菟丝子提取物对雄性生殖功能的影响[J].中国药学杂志1994;29(2):89-90
[39]徐瑶,卞国武,吴敏毓.淫羊藿醇提物对内皮细胞释放NO的影响[J].中药新药与临床药理2001,12(1):38-64
[40]曾炎辉.淫羊藿治疗绝经后骨质疏松症50例[J].陕西中医2005,26(5):405-406
[41]赵丽娜.淫羊藿防治骨质疏松临床效果评价[J].现代中西医结合杂志2003,12(9):922-923
[42]李青南,吴铁,谢华.淫羊藿提取液对去睾丸大鼠骨代谢的影响[J].中草药1993,24(12):637-640
[43]李青南,廖进民,吴铁,黄莲芳.淫羊藿预防羟基脲致雄大鼠骨质疏松的定量研究[J].中国中医骨伤科杂志1996,4(3):1-4
[44]解芳,张岩,吴春福,姚新生,黄文秀.淫羊藿提取物对去卵巢大鼠骨转换率增强的抑制作用[J].中草药2005,36(11):1667-1669
[45]叶纯,苏进,王凡.淫羊藿水提液对去势大鼠松质骨的影响[J].中国临床解剖学杂志2008,26(1):87-90
[46]叶纯,苏进,王凡.淫羊藿影响去势大鼠椎骨微环境中TNF-α、TGF-β1表达的研究[J].中国临床解剖学杂志2006,24(6):687-690
[47]刘道德,王凡,李健,李宁,叶纯.淫羊藿对家兔骨折愈合影响的实验研究[J].四川解剖学杂志2004,12(2):101-105
[48]赵凯,徐胜春.淫羊藿对大鼠退变颈椎骨组织钙、磷代谢的影响[J].安徽中医学院学报2008,27(2):24-26
[49]赵凯,徐胜春,吴建贤,王斌,梁维龙.淫羊蓿对大鼠退变颈椎间盘内IL-1β、IL-6、 TNF-α含量的影响[J].安徽医科大学学报2008,43(3):298-301
[50]洪定钢,时光达.淫羊藿影响骨折愈合的骨组织学及骨组织形态计量学研究[J].中医正骨1999,11(2):3-6
[51]李健,叶纯,刘道德,王凡.含淫羊藿血清对SD大鼠骨体外生长发育的影响[J].四川解剖学杂志2004,12(2):106-109
[52]李芳芳,宋士军,李建平,李恩.淫羊藿对成骨细胞增殖分化的影响[J].中国骨质疏松杂志,1999,5(2):70-72
[53]马涛,崔燎,吴铁,艾春媚,李青南.老年大鼠含淫羊藿血清对成骨细胞的增殖与分化的影响[J].中国骨质疏松杂志,2002;8(1):55-60
[54]王晶,于世凤,庞淑珍.淫羊藿抑制颌骨骨吸收的体外实验研究[J].中国骨质疏松杂志2004,10(3):277-279
[55]陈坤,于世凤,史凤芹,庞淑珍.黔岭藿对体外培养的破骨细胞作用的研究[J].中国骨质疏松杂志1996,2(3):59-61
[56]郑洪军,吕振华,胡有谷,齐宗华,黄公怡.淫羊藿对体外培养破骨细胞的影响[J].中华实验外科杂志2009,17(5):460-461
[57]李晶晶,于世凤,李铁军,庞淑珍.淫羊藿对口腔各矿化组织破骨细胞性骨吸收的体外实验研究[J].中华口腔医学杂志2002,37(5):391-393
[58]冯坤,谢文,陈宝龙,王健智,郭建刚.5种淫羊藿对软骨组织生长和软骨细胞增殖影响的对比研究[J].中国中药杂志2006;31(24):2065-2067
[59]吴白燕,邹俊华,孟书聪,郑振.枸杞子、淫羊藿对衰老.年轻2BS融合细胞DNA合成的影响[J].中国中西医结合杂志2003,23(12):926-928
[60]塞冬.淫羊藿、肉苁蓉、巴戟天对果蝇寿命影响的研究[J].老年医学与保健2004,10(3):140-141
[61]包名家,周维民,王建萍,魏晓东.淫羊藿对D-半乳糖诱导的衰老小鼠大脑皮层一氧化氮的影响[J].中国老年学杂志2005,25(2):460-461
[62]王学美,富宏,刘庚信.淫羊藿、枸杞子对老年大鼠线粒体DNA缺失、线粒体呼吸链酶复合体和ATP合成的影响[J].北京大学学报(医学版)2002,34(1):68-71
[63]秦洛宜,桂伟.淫羊藿对糖皮质激素致大白鼠肾上腺损伤的保护作用[J].中医正骨2002,14(11):9-10
[64]吴铁,崔燎,张志平,李青南,廖进民,黄连芳.淫羊藿对抗肾上腺皮质激素不良反应的实验研究[J].中国中药杂志1996,21(12):748-163
[65]杜娟,凌昌全,陈永安.淫羊藿和熟地煎剂对糖皮质激素受体下调模型大鼠糖皮质激素 受体的影响[J].中国中西医结合杂志2008,28(1):64-67
[66]苗起芬,马俐儒,赵春华,胡宇华.淫羊藿对慢性肾盂肾炎患者血清白介素6、白介素8的影响[J].中国老年学杂志2005,25(10):1177-1178
[67]吴东方,马俊玲,周健,罗顺德.淫羊藿提取液对庆大霉素急性肾损伤的影响[J].中国医院药学杂志2002,22(5):270-271
[68]NIKSIC L,MARTIN P Y.BMP-7(Bone morphogenetic protein-7):a future treatment for chronic renal failure[J].Rev Med Suisse Romande 2005,1(8):568-573
[69]周乐,崔燎,吴铁.淫羊藿对肾阳虚雄性大鼠肾脏BMP-7表达的影响[J].广东医学院学报2007,25(4):371-386
[70]周乐,崔燎,吴铁.淫羊藿对肾阳虚雄性大鼠肾脏和股骨BMP-7表达的影响[J].中国骨质疏松杂志2008,14(2):90-94
[71]陈晓蕾,汤立建,李庆林.淫羊藿、秦皮醇提取物体外抗乳腺癌细胞增殖的研究[J].中国药房2007,18(15):1124-1127
[72]郭海萍,刘晓雁,刘鹏熙,陈秀议,韦熹雯.仙茅、淫羊藿颗粒剂对乳腺癌MCF-7细胞增殖的影响[J].中药材2008,31(5):731-733
[73]郭海萍,刘晓雁,刘鹏熙.淫羊藿颗粒剂联合三苯氧胺对乳腺癌MCF-7细胞增殖的调节作用[J].解剖学研究2008,30(3):181-189
[74]聂红明,汪蓉,胡锦辉,姚成增,金树根,王灵台.淫羊藿水煎液和淫羊藿甙的保肝利胆实验研究[J].实用中医内科杂志2006,20(4):370-372
[75]詹继红,吴晓勇.单味淫羊藿对再生障碍性贫血大鼠细胞因子的影响[J].辽宁中医药大学学报2008,10(3):120-121
[76]谢瑾玉,董竞成,崔众,黄建华,巫善美,陈伟华,应健.淫羊藿对哮喘大鼠肺组织RANTES及MCP-3表达的影响[J].中国中西医结合杂志2008,28(3):238-241
[77]吕莹,牛英鹏,曲天敏.淫羊藿对运动员血糖、血乳酸、血液尿素氮等指标影响的实验研究[J].河南师范大学学报(自然科学版)2000,28(3):93-95
[78]李朝阳,石进校,粟银,唐伟.箭叶淫羊藿叶醇提物对自由基的清除作用[J].华中科技大学学报(自然科学版)2003,31(9):105-107
[79]牛英鹏,吕莹,曲天敏,乔风杰,杨中汉.淫羊藿对羟基自由基的清除作用[J].中国运动医学杂志2000,19(4):434-435
[80]国家药典委员会.中国药典[M].第一部.北京:化学工业出版社2000:267-268
[81]关利新,衣欣,杨履艳,吕怡芳.淫羊藿甙扩血管作用机制的研究[J].中国药理学通报1996,12(4):320-322
[82]潘志伟,王秋娟,徐静,杜保生,孔令义.淫羊藿苷对大鼠离体心脏的作用及对血液流变学的影响[J].中国药科大学学报2007,38(5):429-432
[83]潘志伟,王秋娟,杨涓,孔令义,王蓓.淫羊藿苷对异丙肾上腺素致大鼠急性心肌缺血的影响[J].中国药理学通报2007,23(5):622-625
[84]王英军,孙英莲,唐炜,徐宏,许荔新.淫羊藿总苷对实验动物心血管系统的影响[J].中草药2007,38(1):97-99
[85]Danyan Zhu,Linhai Qu,Xiangnan Zhang,Yijia Lou.Icariin-mediated modulation of cell cycle and p53 during cardiomyocyte differentiation in embryonic stem cells.European Journal of Pharmacology 2005(514):99-110
[86]汪晶晶,唐其柱,王腾,刘淼,王小玲.淫羊藿苷对兔心室肌细胞L-型钙电流的影响[J].武汉大学学报(医学版)2007,28(3):282-286
[87]潘志伟,王秋娟,柳仁民,孔令义.淫羊藿苷预适应对乳鼠心肌细胞的保护作用[J].中国药科大学学报2007,38(1):73-76
[88]刘桦,季晖,张超英.淫羊藿苷对异丙肾上腺素所致乳鼠心肌细胞损伤的保护作用[J].中国药理学通报2006,22(12):1509-1512
[89]Qiu-Juan Wang,Zhi-Wei Pan,YuWang,Juan Yang,Ying Jia and Ling-Yi Kong.Protective effects of icariin on human umbilical vein endothelial cell injured by angiotensin Ⅱ[J].Journal of Chinese Pharmaceutical Sciences 2008,17:16-21
[90]王茜,林焕冰,程玉芳,徐江平.淫羊藿苷对高脂血症大鼠粘附分子基因表达的影响[J].中国动脉硬化杂志2008,16(1):4-6
[91]王敏,刘崇铭,张宝风.淫羊藿苷扩张脑血管作用的研究[J].沈阳药学院学报1992,8(4):272-274
[92]李梨,周岐新,杨俊卿,石京山.淫羊藿甙对脑缺血再灌损伤小鼠的保护作用[J].四川生理科学杂志2004,26(4):173-175
[93]李梨,吴芹,周岐新,石京山.淫羊藿苷对氧自由基所致大鼠脑线粒体损伤的保护作用[J].中国药理学与毒理学杂志2005,19(5):333-337
[94]Lin Wang,Ling Zhang,Zhi-Bin Chen,Jia-Yong Wu,Xin Zhang,Yun Xu.lcariin enhances neuronal survival after oxygen and glucose deprivation by increasing SIRTI.European Journal of Pharmacology 2009(待发)
[95]肖幸丰,郑明,瞿林海,张幸国,楼宜嘉.淫羊藿苷伍用三七总皂苷对Aβ-淀粉肽25-35侧脑室注射所致大鼠行为异常及脑组织AchE活性的影响[J].中国现代应用药学杂志2005,22(3):178-181
[96]徐瑞霞,吴芹,龚其海,罗璨,石京山.淫羊藿苷防治血管性痴呆的实验研究[J].四川 生理科学杂志2004,26(4):174-175
[97]罗勇,聂晶,龚其海,陆远富,吴芹,石京山.淫羊藿苷对三氯化铝诱导痴呆大鼠模型脑内胆碱能系统的影响[J].上海中医药杂志2008,42(4):69-72
[98]罗勇,聂晶,龚其海,陆远富,吴芹,石京山.淫羊藿苷减轻铝诱导的大鼠学习记忆减退并增强皮质及海马Na~+-K~+-ATPase、Ca~(2+)-ATPase活性[J].中药药理与临床2008,24(3):24-25
[99]聂晶,罗勇,黄燮南,陆远富,孙安盛,龚其海,石京山.淫羊藿苷对淀粉样β蛋白片段25-35所致大鼠学习记忆障碍的改善作用[J].中国药理学与毒理学杂志2008,22(1):31-37
[100]王俊勤,胡有谷,郑洪军,齐宗华.淫羊藿甙对体外培养成骨细胞增殖和分化的影响[J].中国临床康复2002,6(9):1307-1308
[101]殷晓雪,陈仲强,党耕町.葛根素和淫羊藿甙对成骨细胞生物学作用的比较研究[J].中国骨与关节损伤杂志2007,22(3):210-212
[102]Jiyuan Zhao,Shinsuke Ohba,Masashige Shinkai,Ung-il Chung,Teruyuki Nagamune.Icariin induces osteogenic dierentiation invitro in a BMP- and Runx2-dependent manner.Biochemical and Biophysical Research Communications 2008(369):444-448
[103]胡云峰,侯加法,邓益锋,周振雷,姚静.淫羊藿苷对鸡胚成骨细胞增殖和分化的影响[J].中国农学通报2007,23(3):43-46
[104]李淑梅,宋利格,张秀珍.淫羊藿甙对大鼠成骨细胞功能及Osterix表达的影响[J].同济大学学报(医学版)2005,26(6):8-11
[105]于波,杨久山,刘岩,董建文.淫羊藿苷对人成骨细胞的作用[J].中医正骨2006,18(6):17-18
[106]张立娟,雷涛,张秀珍.淫羊藿甙对成骨细胞凋亡的影响[J].同济大学学报(医学版)2008,29(1):30-33
[107]刘素彩,孔德娟,赵京山,李恩.淫羊藿甙对大鼠成骨细胞增殖与分化的影响[J].中国中医基础医学杂志2001,7(8):28-30
[108]陈虹,张秀珍.淫羊藿甙对大鼠成骨细胞分泌细胞因子的影响[J].同济大学学报(医学版)2005,26(2):5-16
[109]雪原,王沛,齐清会,倪虹,马信龙,郭世绂.淫羊藿甙对成骨细胞smad4 mRNA作用的实验研究[J].中华骨科杂志2005,25(2):119-123
[110]吕明波,刘兴炎,葛宝丰,陈克明,白孟海,汪玉海,顾九君,马丽萍.淫羊藿苷对破骨细胞活性的影响[J].中国骨伤2007,20(8):529-531
[111]吕明波,刘兴炎,葛宝丰,陈克明,白孟海.淫羊藿苷对小鼠骨髓源性破骨细胞诱导生成及骨吸收功能的影响[J].中国骨质疏松杂志2007,13(5):315-317
[112]黄健,张金超,张天蓝,许善锦,王夔.淫羊藿苷对破骨细胞骨吸收功能的影响及其作用机制[J].科学通报2006,51(24):2851-2856
[113]刘海江,王小平,林娟,余优成,蒋欣泉,张秀丽,周曾同,张卫东.淫羊藿苷和黄芪苷Ⅰ对骨髓基质细胞增殖及成骨能力的影响[J].中药材2006,29(10):1062-1065
[114]陈克明,葛宝丰,马慧萍,刘兴炎,白孟海,马丽萍,吕明波.淫羊藿苷对体外培养骨髓基质干细胞成骨性分化的影响[J].中国骨质疏松杂志2008,14(9):642-645
[115]谢玲玲,邹移海,刘炫斯.淫羊藿苷对骨髓间质干细胞增殖及分泌血管内皮生长因子、碱性成纤维生长因子的影响[J].实用医学杂志2008,24(6):908-910
[116]葛林阜,董政军,姜国胜.淫羊藿苷对小鼠免疫调节作用的研究[J].中华实用医学2001,3(3):25-27
[117]滕菲,曾耀英,黄秀艳,杨志,姚满林,宋兵,李林.淫羊藿甙对小鼠腹腔巨噬细胞体外增殖、吞噬和产生NO的影响[J].2008,28(5):372-375
[118]罗昭华,唐彦萍,袁谨,徐红.淫羊藿甙对巨噬细胞iNOS和TNF-ctmRNA的影响[J].遵义医学院学报2005,28(5):409-411
[119]李书桐,李铁军,郑钦岳,王洪斌.淫羊藿甙对小鼠腹腔巨噬细胞功能的影响[J].第三军医大学学报1996,16(6):541-543
[120]毕可红,张玉昆,葛林阜,董政军,唐天华,任海全,黄宁,姜国胜.淫羊藿苷对受照小鼠免疫与造血功能的影响[J].中国辐射卫生2001,10(6):104-105
[121]李晓冰,金东庆,郭良君,唐天华,张玉昆,任海泉,葛林阜.淫羊藿苷在辐射小鼠免疫学功能恢复中作用的研究[J].中国辐射卫生2002,11(3):171-173
[122]王天然,邢善田,周金黄.淫羊藿苷促进抗体生成的作用[J].药学通报,1987,9:533-535
[123]李书桐,李铁军,郑钦岳.王洪斌.淫羊藿苷对小鼠体外脾脏细胞增殖及产生集落刺激因子样活性的影响[J].第二军医大学学报1995,16(4):340-342
[124]肖幸丰,王志强,楼宜嘉.淫羊藿苷伍用三七总皂苷对小鼠免疫功能的调节作用[J].中草药2006,37(6):888-891
[125]赵勇,张玲,王芸,毛海婷,崔正言.淫羊藿苷的体外免疫调节作用研究[J].中草药1996,27(11):669-673
[126]曹颖瑛,郑钦岳,张国庆,曹尉尉.淫羊藿苷促进小鼠脾细胞IL-3mRNA及IL-6mRNA 的表达[J].第二军医大学学报1998,19(2):199-200
[127]Liu TH,Wang BX,Wang Y.Effect of icariin and its metabolites on the production of cytokines by THP-lcells[J].Acta Pharmaceutica Sinica 2000,35(4):245-249
[128]李晓燕,张玲,王芸,毛海婷,刘炬,温培娥.淫羊藿苷逆转转化生长因子对LAK、CD3AK细胞的免疫抑制作用[J].中国免疫学杂志2000,16(5):266-270
[129]赵勇,张玲,崔止言.淫羊藿苷对HL-60细胞增殖与分化的影响[J].中国药理学通报1996,12(1):52-54
[130]赵勇,崔正言,张玲,李淑贞.MTT法检测淫羊藿甙对几种瘤细胞株增殖的抑制作用[J].上海免疫学杂志1995,15(3):167-168
[131]葛林阜,董政军,姜国胜.淫羊藿苷对急性早幼粒白血病细胞端粒酶活性的影响[J].中国肿瘤生物治疗杂志2002,9(1):36-38
[132]张玲,王芸,毛海婷,温培娥,崔树龄,李晓冰.淫羊藿苷抑制肿瘤细胞端粒酶活性及其调节机制的研究[J].中国免疫学杂志2002,18(3):191-196
[133]李贵新,张玲,王芸.淫羊藿苷诱导肿瘤细胞凋亡及其机制的研究[J].中国肿瘤生物治疗杂志1999,6(2):131-135
[134]李贵新,张玲,王芸,毛海婷,郭鸣.淫羊藿甙诱导白血病细胞凋亡及其对癌基因表达的影响[J].中华血液学杂志2002,23(6):322-323
[135]王伟,张涛,赵明镜.5种中药黄酮对血管平滑肌细胞凋亡的交互作用[J].北京中医药大学学报2000,23(4):18-20
[136]阂红波,王建文,孙继虎,黄勤,步世忠.淫羊霍甙诱导视网膜母细胞瘤细胞凋亡及对Bcl-2的影响.中国中西医结合杂志2003,23(6)基础理论研究特集:147-149
[137]王谦,张玲,毛海婷,顾洪涛,温培娥,李翠玲,杨尚军,夏武青.中药淫羊藿苷逆转肝癌HepG2.2.15细胞恶性表型及诱导分化研究[J].世界华人消化杂志2007,15(19):2087-2092
[138]李翠玲,张玲,顾洪涛,王军,毛海婷,杨尚军,温培娥.淫羊藿苷体内抑瘤作用及其机制[J].中国肿瘤生物治疗杂志2007.114(2):137-142
[139]毛海婷,张玲,王芸.Ica和PJA对高转移性人肺癌细胞体外侵袭转移能力抑制的研究[J].中国免疫学杂志2001,17(1):27-29
[140]毛海婷,张玲,王芸.淫羊藿甙和济南假单胞菌制剂调控PG细胞转移相关基因的表达[J].肿瘤2000,20(1):13-15
[141]毛海婷,张玲,王芸,李晓冰.淫羊藿苷及济南假单胞菌制剂联合应用体外抗转移的研究[J].中国药理学通报2000,16(5):534-537
[142]毛海婷,张玲,王芸,温培峨,崔树龄.淫羊藿甙对人高转移肺癌细胞膜的影响[J].中药材1999,19(1):35-36
[143]唐菁,张玲,顾洪涛,李翠玲,毛海婷,杨尚军,温培娥,阴海鹏.淫羊藿苷、黄芩苷联合多柔比星抑制肝癌细胞APRIL表达和逆转肿瘤免疫逃逸[J].中国肿瘤生物治疗杂志2007,14(6):516-521
[144]张京伟,周云峰,文显梅,魏蕾,杨国梁.淫羊藿甙逆转胃癌细胞恶性表型的研究[J].中华实验外科杂志2006,23(10):1213-1214
[145]李晓燕,张玲,王芸.淫羊藿甙逆转转化生长因子β_2免疫抑制作用的抗肿瘤研究[J].中国肿瘤生物治疗杂志2000,7(2):127-130
[146]王大光,朱文元,马慧军.淫羊藿苷等6种中药单体抑制Cloudman S91黑素瘤细胞株黑素合成的研究[J].临床皮肤科杂志2004,33(4):202-205
[147]李芳芳,李思,吕占军.淫羊藿苷对大鼠卵泡颗粒细胞和肾上腺皮质细胞分泌功能的影响[J].中国中药杂志1997,22(8):499-451
[148]秦路平,石汉平,郑水庆.Osthol和Icariin对甲减小鼠血清甲状腺激素的影响[J].第二军医大学学报1998,19(1):48-52
[149]钟瑜,李晓清,徐晓玉,陈琳,杨国汉.淫羊藿苷对肾阳虚细胞糖皮质激素受体表达影响的研究[J].中国药房2007,18(36):2801-2803
[150]李波,安睿,王新宏.淫羊藿苷和补肾复方对肾阳虚大鼠下丘脑CRH基因和垂体POMC基因表达的影响[J].中成药2008,30(1):132-134
[151]付杰,乔梁,金泰乙,林桂亭,王银叶,辛钟成.淫羊藿苷对家兔阴茎海绵体cGMP浓度的效果[J].中国药理学通报2002,18(4):430-433
[152]蒋兆健,胡本容,付琴,汤强,向继洲,刘菊妍.淫羊藿苷对家兔阴茎海绵体环核苷酸水平的影响[J].华中科技大学学报(医学版)2007,36(2):166-168
[153]田龙,辛钟成,刘武江,袁亦铭,刘刚,陈亮,付杰,王玲珑.淫羊藿苷对动脉性ED模型大鼠阴茎海绵体压力和一氧化氮合酶亚型表达的影响[J].中华医学杂志2004,84(11):954-957
[154]章振保,杨庆涛,杨镜秋,郑俊鸿,周德荣.淫羊藿甙、菟丝子提取物对雄激素部分缺乏大鼠生殖保护作用的比较研究[J].中国老年学杂志2006,26(10):1389-1391
[155]章振保,田生平,杨镜秋,蔡崇岳.淫羊藿与睾酮治疗亚急性衰老雄性大鼠的实验研究[J].中国男科学杂志2006,20(8):13-17
[156]杨春,辛钟成,付杰,袁亦铭,丁义,辛华,汪泽厚.淫羊藿苷对兔阴蒂海绵体平滑肌细胞NO及NOS活性的影响[J].中国男科学杂志2005,19(1):5-10
[157]黄菊,罗丽莉,傅玉才,钱元恕,许锦阶.淫羊藿甙对大鼠早期卵巢卵泡发育和卵母细胞凋亡影响的初步研究[J].中国现代医学杂志2007,17(5):523-527
[158]Kuroda M,Mimaki Y,Sashida Y,Umegaki E,Yamazaki M,Chiba K,Mohri T,Kitahara M,Yasuda A,Naoi N,Xu ZW,Li MR.Flavonol glycosides from Epimedium sagittatum and their neurite outgrowth activity on PC12h cells[J].Planta Medica 2000,66(6):575-577
[159]Lee MK,Choi Y J,Sung SH,Shin DI,Kim JW,Kim YC.Antihepatotoxic activity of icariin,a major constituent of Epimedium koreanum[J].Planta Medica 1995;61(6):523-526
[160]Zhang Y W,Morita 1,Shao G,Yao X S,Murota S.Screening of anti-hypoxia/reoxygenation agents by an in vitro model.Part 1:Natural inhibitors for protein tyrosine kinase activated by hypoxia/reoxygenation in cultured human umbilical vein endothelial cells[J],Planta Medica 2000,66(2),114-118
[161]王国芳,吴织芬,万玲,王勤涛.淫羊藿苷对人牙周膜细胞增殖和骨保护素mRNA表达的影响[J].牙体牙髓牙周病学杂志2006,16(4):223-225
[162]张奉学,张俊丽,符林春,邓文娣,吴爱武,王新华.淫羊藿苷体外抑制SIV感染诱导的CEMx174细胞凋亡[J].中国药理学通报2008,24(5):684-687
[163]徐文,张亚萍,张卫东,张新民,沈自尹.离体大鼠肠道菌群对淫羊藿苷的代谢研究[J].2006,8(6):98-100
[164]MIKSICEK R J.Estrogenic flavonoids:structural requirements for biological activity[J].Proc Soc Exp Biol Meal 1995,208(1):44-50.
[165]Kelly GE,Nelson C,Waring MA,Joannou GE.Metabolites of dietary(soya) isoflavones in humans urine[J].International Journal of Clinical Chemistry 1993,223(1-2):9-22.
[166]赵艳红,贾晓斌,陈彦,范晨怡,Ming Hu.淫羊藿黄酮类化合物的大鼠在体肠吸收研究[J].中国药学杂志2008,43(3):188-191
[167]邱峰,陈英杰,鹿野美弘,姚新生.淫羊藿苷在大鼠体内的代谢[J].药学学报Acta Pharmaceutica Sinica 1999,34(3):222-226
[168]刘铁汉,王毅,王本祥.淫羊藿苷的肠菌代谢研究Ⅰ.肠内细菌对淫羊藿苷的代谢转化[J].中草药2000,31(11):834-837
[169]徐金丽,姜晓野,鱼红闪,安东善,柳青梅,任皖泽,金凤燮.水解淫羊藿苷糖基的土壤细菌筛选[J].大连轻工业学院学报2007,26(4):303-305
[170]刘铁汉,王本祥,王毅,吴立军,南陆彦,永田年,池岛乔.淫羊藿苷及其肠菌代谢产物对THP-1细胞分泌细胞因子的影响[J].Acta Pharmaceutica Sinica 2000,35(4):245-248
[171]LIU Jian,YE Hai-yong,LOU Yi-jia.Determination of rat urinary metabolites of icariin in vivo and estrogenic activities of its metabolites on MCF-7 cells[J].Die Pharmazie,2005,2005,60(2):120-125
[172]叶海涌,刘健,楼宜嘉.淫羊藿苷衍生物的制备及其雌激素样作用研究[J].浙江大学学 报(医学版)2005,34(2):131-136
[173]张翔南,王欢欢,王志强,吴佳莹,朱丹雁,楼宜嘉.淫羊藿素抗Aβ肽致大鼠原代培养神经细胞凋亡作用[J].浙江大学学报(医学版)2007,36(3):223-228
[174]朱丹雁,张翔南,杜悦,陈燕,王忐强,楼宜嘉.淫羊藿素诱导小鼠胚胎干细胞体外定向分化为神经细胞[J].浙江大学学报(医学版)2007,36(3):218-223
[175]张天蓝,黄健,许善锦,王夔.淫羊藿黄酮苷及其代谢产物调控骨代谢的体外实验研究[J].首都医科大学学报2005,26(1):37-38
[176]Jian Huang,LanYuan,Xi Wang,Tian-Lan Zhang,Kui Wang.Icaritin and its glycosides enhance osteoblastic,but suppress osteoclastic,differentiation and activity in vitro[J].Life Sciences 2007,(81)832-840
[177]Yang Li,Zhang Rong-hua(张荣华),Zhu Xiao-feng.Effects ofbenefiting-bone capsule on expression of bone morphogenetic protein-2 in bone tissue 0f the ovariectomized rats[J].Chinese Journal of Clinical Rehabilitation 2006,10(3):190-192
[178]廖清船,肖洲生,秦艳芳,刘亭,赵彦,周宏灏.植物雌激素金雀异黄酮通过p38MAPK 通路促进骨髓间充质干细胞向成骨细胞分化[J].中国药理学通报2006,22(6):683-687
[179]Po-Lin Kuo,Ya-Ling Hsu,Cheng-Hsiung Chang,and Jiunn-Kae Chang.Osthole-Mediated Cell Differentiation through Bone Morphogenetic Protein-2/p38 and Extracellular Signal-Regulated Kinase 1/2 Pathway in Human Osteoblast Cells[J].Journal of Pharmacology And Experimental Therapeutics 2005,18(10):1290-1299
[180]Si-Yuan Tang,Hui Xie,Ling-Qing Yuan,Xiang-Hang Luo,Jiao Huang,Rong-Rong Cui,Hou-De Zhou,Xian-Ping Wu,Er-Yuan Liao.Apelin stimulates proliferation and suppresses apoptosis of mouse osteoblastic cell line MC3T3-E1 via JNKand Pl3oK/Akt signaling pathways[J].Peptides 2007,(28):708-718
[181]Ji-Cheon Jeong,Jae-Wook Lee,Cheol-Ho Yoon,Hyung-Min Kim,CheorI-Ho Kim.Drynariae Rhizoma promotes osteoblast dierentiation and mineralization in MC3T3-E1 cells through regulation of bone morphogeneticprotein-2,alkalinephosphatase,type Ⅰ collagen and collagenase-1[J].Toxicology in Vitro 2004,(18):829-834
[182]程宝莺主编.动物细胞培养技术[M].广州:华南理工大学出版社.2001年第一版:80-132
[183]Chih-Hsin Tang,Rong-Sen Yang,Mei-Yin Chien,Chien-Chich Chen and Wen-Mei Fu.Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts[J].European Journal of Pharmacology 2008,579(28):40-49
[184]Bruder SP,Jaiswal N,Ricalton NS,Mosca JD,Kraus KH,Kadiyala S.Mesenchymal stem cells in osteobiology and applied bone regeneration[J].Clinical Orthopaedics And Related Research 1998,355(3):247-256.
[185]Sierra RI,Specker BL,Jim(?)nez F,Cruz C,Pedraza-Chaverr(?) J.Biochmical bone markers,bone mineral content,and bone mineral density in rats with experimental nephrotic syndrome[J].Renal Failure,1997;19(3):409-424
[186]By Kihara T,Oshima A,Hirose M,Ohgushi H.Tree-dimensional visualization analysis of in vitro cultured bone fabricated by rat marrow mesenchymai stem cells[J].Biochemical and Biophysical Research Communications 2004,316:943-948
[187]Abdallah BM,Jensen CH,Gutierrez GI.Regulation of human skeletal stem celils diferentiation by Dlkl/Pref-1[J].J Bone Miner Res 2004,19(5):841-852.
[188]Sammons J,Ahmed N.The role of BMP-6,IL-6,and BMP-4 in mesenchymal stem cell-dependent bone development:effects on osteoblastic differentiation induced by parathyroid hormone and vitaminD(3)[J].Stem Cells,2004;13(3):273-280
[189]高莉莉,任宪辉,富宏然.骨源性碱性磷酸酶在骨代谢疾病诊断中的应用[J].牡丹江医学院学报2009,30(1):50-51
[190]李德华,刘宝林,吴军正,陈建元.体外培养的成骨细胞中碱性磷酸酶活性的检测方法探讨[J].实用口腔医学杂志1997,13(1):21-22
[191]柯青,刘海全,牛维.补肾方药对绝经后骨质疏松症患者骨密度及血钙、血清碱性磷酸酶的影响[J].中国临床康复2005,9(31):186-189
[192]邢国胜,谈志龙,王淑云,白人骁,沈启捷,禹军.补肾健骨汤对成骨细胞增殖及碱性磷酸酶、骨钙素合成的影响[J].2001,32(11):1020-1022
[193]邵培.桂皮醛对成骨细胞的增殖及其碱性磷酸酶活性的影响.四川大学华西口腔医学院硕士学位论文2007,5:16-25
[194]侯玉.p物质和降钙素基因相关肤对成骨细胞的增殖和碱性磷酸酶活性的影响.第四军医大学硕士学位论文2006,5:21-32
[195]Xu Q,Tian XX.The research on the differentiative produce and the biochemistry standard of osteoblast[J].Clinical Foucus,2003;18(1):55-60
[196]Heino T J,Hentunen TA,Vaananen HK.Conditioned medium from osteocytes stimulates the proliferation of bone marrow mesenchymal stem cells and their differentiation into osteoblasts[J].Experimental Cell Research 2004,294:458-466
[197]徐青,田小秀.成骨细胞分化产物及其生化标准研究进展[J].临床荟萃,2003:18(1):55-56
[198]Collal-driven transgenic markers of osteoblast lineage progression.Collal-driven transgenic markers of osteoblast lineage progression[J].J Bone Miner Res,2001;16(7):1228-1236
[199]Bodine PV,Komm BS.Evidence that conditionally immortalized human osteoblasts express ano steocalcin receptor[J].Bone,1999,25:535-543
[200]Jurutka PW,MacDonald PN,Nakajima S.Isolation ofbaculovirus expressed human vitamin D receptor:DNA responsive element interactions and phosphorylation of the purified receptor[J].J Cell Biochem,2002,85:435-457
[201]刘梅沽,吕国红,邹军,于智敏,王燕平,赵宏艳,鞠大宏.左归丸含药血清对成骨细胞分泌骨钙素的影响[J].中国中医基础医学杂志2007,13(8):581-582
[202]王建华,李力更,冯风莲.染料木素对大鼠成骨细胞骨钙素表达的影响[J].中药药理与临床2004;20(5):10-11
[203]Oxlund H,Mosekilde L,Ouoft G.Reduced concentration of collagen reducible cross links in human trabecullar bone with respect to age and osteoporosis[J].Bone 1996,19:479-484.
[204]Hosoi T.Bone and bone related biochemical examinations Bone and colagen related metabolites Structure and metabolisms of collagen[J].Clin Calcium,2006,16(6):971-980
[205]Charles P,Mosekilde L,Risteli L,Risteli J,Eriksen EF.Assessment of bone remodeling using biochemical indicators of type Ⅰcollagen synthesis and degredation:relation to calcium kinetics[J].Bone And Mineral 1994,(24):81-94
[206]Wenstrup RJ,Witte DP,Florer JB.Abnormal differentiation in MC3T3-E1 preosteoblasts expressing a dominant-negative type Ⅰcollagen mutation[J].Connective Tissue Research 1996,35(1-4):249-257
[207]Garnero P,Somay-Rendu E,Chapuy MC,Delmas PD.Increased bone tumover in late postmenopausal women is a major determinant of osteoporosis[J].J Bone Miner Res 1996,(11):337-349
[208]Hosoi T.Bone and bone related biochemical examinations Bone and colagen related metabolites Structure and metabolisms of collagen[J].Clin Calcium 2006;16(6):971-980
[209]Stein GS,Lian JB,Stein JL,Van Wijnen A J,Montecino M.Transcriptional control of osteoblast growth and differentiation[J].Physiological reviews 1996,76:593-599
[210]Galvin RJ,Cullison JW,Avioli LV.Influence of osteoclasts and osteoclast-like cells on osteoblast alkaline phosphatase activity and collagen synthesis[J].J Bone Miner Res 1994,9(8):1167-1178
[211]Chen TL,Bates RL.Recombinant human transforming growth factor beta 1 modulates bone remodeling in a mineralizing bone organ culture[J].J Bone Miner Res 1993,8(4):423-434
[212]徐传毅,何伟,方斌,樊粤光,袁浩.生脉成骨方对股骨头坏死Ⅰ型胶原表达的调节作用研究[J].现代中西医结合杂志2003,12(6):574-576
[213]常红,黄国伟,刘莉,任大琳,王媛.染料木黄酮对成骨细胞Ⅰ型胶原表达及转化生长因子β1的影响[J].Aeta Nutrimenta Sinica 2008,30(2):194-198
[214]Prouillet C,Mazi(?)re JC,Mazi(?)re C,Wattel A,Brazier M,Kamel S.Stimulatory effect of naturally occurring flavonols quercetin and kaempferol on alkaline phosphatase activity in MG-63 human osteoblasts through ERK and estrogen receptor pathway[J].Biochem Pharmacol.2004,67(7):1307-1313
[215]Shang Y,Hu X,DiRenzo J,Lazar MA,Brown M.Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription.Cell 2000,103 (6):843-852
[216]Smith CL.Cross-talk between peptide growth factor and estrogen receptor signaling pathways[J].Biology Of Reproduction 1998,58(3):627-632
[217]Ueda S,Tsuda H,Sato K,Takeuchi H,Shigekawa T,Matsubara O,Hiraide H,Mochizuki H.Alternative tyrosine phosphorylation of signaling kinases according to hormone receptor status in breast cancer overexpressing the insulin-like growth factor receptor type 1[J].Cancer Science 2006,97(7):597-604
[218]Lannigan DA.Estrogen receptor phosphorylation^].Steroids 2003,68(1):1-9
[219]Tremblay A,Giguere V.Contribution of steroid receptor coacti vator-1 and CREB binding protein in ligand-independent activity of estrogen receptor beta[J].J Steroid Biochem Mol Biol 2001,(77):19-27
[220]Paech K,Webb P,Kuiper GG,et al.Differential ligand activation of estrogen receptors ERaand ERpat AP1 sites[J].Science 1997,277 (5331):1508-1510
[221]PappasT C,Gametchu B,W atson C S.Membrane estrogen receptors identified by multiple antibody labeling and impededligand binding[J].The FASEB Journal 1995,9(5):404-410
[222]Razandi M,Pedram A,Greene GL,Levin ER.Cell membrane and nuclear estrogen receptors(ERs)originate from a single transcript:studies of Era and Erp expressed in Chinese hamster ovary cells[J].Molecular Endocrinology 1999,13(2):307-319
[223]Hisamoto K,Bender JR.Vascular cell signaling by membrane estrogen receptors[J].Steroids 2005,70 (5-7):382-387
[224]Morey AK,Razandi M,Pedram A,Hu RM,Prins BA,Levin ER.Oestrogen and progesterone inhibit the stimulated production of endothelin-l[J].The Biochemical Journal 1998,330(3):1097-1105
[225]Kousteni S,Bellido T,Plotkin LI,O'Brien CA,Bodenner DL,Han L,Han K,DiGregorio GB,Katzenellenbogen JA,Katzenellenbogen BS,Roberson PK,Weinstein RS,Jilka RL,Manolagas SC.Nongenotropic,sex-nonspecific signaling through the estrogen or androgen receptors:dissociation from transcriptional activity[J].Cell 2001,(104):719-730
[226]Howell A,Osborne CK,Morris C,Wakeling AE.ICI 182,780 (Faslodex):development of a novel,"pure" antiestrogen [J].Cancer 2000,89(4):817-825
[227]孟庆书,何平,朱晓燕,倪鑫．植物雌激素的作用机制[J]．生命的化学2007,27(2)：142-143
[228]Johnson GL,Lapadat R.Mitogen-activated protein kinase pathways mediated by ERK,JNK, and p38 protein kinases[J].Science 2002,298(5600):1911-1912
[229]Chang L,Karin M.Mammal inaMAP kinase signaling cascades[J].Nature 2001,410:37-40.
[230]Jaiswal RK,Jaiswal N,Bruder SP,Mbalaviele G,Marshak DR,Pittenger MF.Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase[J].The Journal Of Biological Chemistry 2000,275(73):9645-9652
[231]Oyama M,Chiba J,Kato Y,lgarashi N,Yoshida M,lshigami M,Sugawara S,Kobayashi M.Distribution and expression of mRNAs for the proto-oncogenes c-fos and c-jun in bone cells in vivo[J].Histology And Histopathology 1998,13(3):671-678
[232]Suzawa M,Takada I,Yanagisawa J,Ohtake F,Ogawa S,Yamauchi T,Kadowaki T,Takeuchi Y,Shibuya H,Gotoh Y,Matsumoto K,Kato S.Cytokines suppress adipogenesis and PPAR-gamma function through the TAK1/TAB1/NIK cascade[J].Nature Cell Biology 2003,5(3):224-230
[233]Suzuki A,Guicheux J,Palmer G,Miura Y,Oiso Y,Bonjour JP,Caverzasio J.Evidence for a role of p38 MAP kinase in expression of alkaline phosphatase during osteoblastic cell differentiation[J].Bone 2002,30(1):91-98
[234]Lee KS,Hong SH,Bae SC.Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein[J].Oncogene 2002,21(47):7156-7163
[235]黄鲁豫,胡蕴玉,明井阳西,川昌孝吉,川秀树,陶惠人.p38丝裂原活化蛋白激酶信号途径在鼠破骨细胞生成和骨吸收中的作用[J].中华风湿病学杂志2006,10(4):202-205
[236]张文军,李荣山.p38丝裂原活化蛋白激酶通路及其研究进展[J].医学综述2007,13(9):663-665
[237]Brewster JL,De Valoir T,Dwyer N,et al.An osmosensing signal transduction pathway in yeast[J].Science 1993,259(5099):1760-1763.
[238]Han J,Lee JD,Bibbs L,Ulevitch RJ,.A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells[J].Science 1994,265(5173):808-811
[239]Raingeaud J,Whitmarsh AJ,Barrett T;D(?)rijard B,Davis RJ.MKK3 and MKK6 regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway[J].Molecular And Cellular Biology 1996,16(3):1247-1255
[240]Obata T,Brown GE,Yaffe MB.MAP kinase pathways activated by stress:the p38MAPK pathway[J].Critical Care Medicine 2000,28(4):67-77
[241]A.Rey,D.Manen,R.Rizzoli,S.L.Ferrari,J.Caverzasio.Evidences for a role of p38MAP kinase in the stimulation of alkaline phosphatase and matrix mineralization induced by parathyroid hormone in osteoblastic cells[J].Bone 2007,(41):59-67
[242]A.Ishisaki,H.Tokuda,M.Yoshida,K.Hirade,K.Kunieda,D.Hatakeyama,T.Shibata,O. Kozawa.Activation of p38 mitogen-activated protein kinase mediates thyroid hormone-stimulated osteocalcin synthesis in osteoblasts[J].Molecular and Cellular Endocrinology 2004,(214):189-195
[243]Kyeong-Sook Lee,Hyun-Jung Kim,Qing-Lin Li,Xin-Zi Chi,Chisato Ueta,Toshihisa Komori,John M.Wozney,Eung-Gook Kim,Je-Young Choi,Hyun-Mo Ryoo,and Suk-Chul Bae.Runx2 ls a Common Target of Transforming Growth Factor β1 and Bone Morphogenetic Protein 2,and Cooperation between Runx2 and Smad5 Induces Osteoblast-Specific Gene Expression in the Pluripotent Mesenchymal Precursor Cell Line C2C12[J].Molecular and Cellular Biology.2000,20(23):8783-8792
[244]Ekaterini Pantouli,Matthew M.Boehm,Sreenivas Koka.Inflammatory cytokines activate p38MAPK to induce osteoprotegerin synthesis by MG-63 cells[J].Biochemical and Biophysical Research Communications 2005(329):224-229
[245]Chiho Minamitani,Takanobu Otsuka,Shinji Takai,Rie Matsushima-Nishiwaki,Seiji Adachi,Yoshiteru Hanai,Jun Mizutani,Haruhiko Tokuda,Osamu Kozawa.Involvement of Rho-kinase in prostaglandin F2α-stimulated interleukin-6 synthesis via p38mitogen-activated protein kinase in osteoblasts[J].Molecular and Cellular Endocrinology 2008,(291):27-32
[246]Xiang-Hang Luo,Li-Juan Guo,Ling-Qing Yuan,Hui Xie,Hou-De Zhou,Xian-Ping Wu,Er-Yuan Liao.Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway[J].Experimental Cell Research 2005(309):99-109
[247]UlrichNoth,Richard Tuli,Reza Seghatoleslami,Michael Howard,Asit Shah,David J.Hall,Noreen J.Hickok,and Rocky S.Tuan.Activation of p38 and Smads mediates BMP-2 effects on human trabecular bone-derived osteoblasts[J].Experimental Cell Research 2003(291):201-211
[248]黄少慧,李娟,赵毅,张娟.补肾中药骨灵片对人成骨细胞功能和p38活化原蛋白激酶通路的影响[J].热带医学杂志2007,7(5):418-425
[249]Chih-Hsin Tang,Rong-Sen Yang,Mei-Yin Chien,Chien-Chich Chen,Wen-Mei Fu.Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts[J].European Journal of Pharmacology 2008(579):40-49
[250]Ya-Ling Hsu,Jiunn-Kae Chang,Chu-Hung Tsai,Tzu-Tsung Chang Chien,Po-Lin Kuo.Myricetin induces human osteoblast differentiation through bone morphogenetic protein-2/p38mitogen-activated protein kinase pathway[J].Biochemical pharmacology 2007,(73):504-514
[251]Masatake Izumi,Masahito Watanabe,Kohei Sawaki,Hideharu Yamaguchi,Mitsuru Kawaguchi.Expression of BMP7 is associated with resistance to diabetic stress: Comparison among mouse salivary glands.European Journal of Pharmacology 2008,596(7):1-5
[252]Termaat MF,Den Boer FC,Bakker FC,Patka P,Haarman HJThM.Bone morphogenetic proteins.Development and clinical efficacy in the treatment of fractures and bone defects [J].The Journal Of Bone And Joint Surgery 2005,87A(6):1367-1378
[253]Groeneveld EH,Burger EH.Bone morphogenetic proteins in human bone regeneration[J].European Journal Of Endocrinology 2000,142(1):9-21.
[254]Shigeyuki Kato,Niki Kawabata,Naoto Suzuki,Masako Ohmura,Minoru Takagi.Bone morphogenetic protein-2 induces the differentiation of a mesenchymal progenitor cell line,ROB-C26,into mature osteoblasts and adipocytes[J].Life Sciences 2009 (84):302-310
[255]Saito T,Ogawa M,Hata Y,Bessho K.Acceleration Effect of Human Recombinant Bone Morphogenetic Protein-2 on Differentiation of Human Pulp Cells Into Odontoblasts[J].Journal Of Endodontics 2004,30 (4):205-208
[256]W.Singhatanadgit,V.Salih,I.Olsen.RNA interference of the BMPR-IB gene blocks BMP-2-induced osteogenic gene expression in human bone cells[J].Cell Biology International 2008,(32):1362-1370
[257]Yamaguchi A,Komori T,Suda T.Regulation of osteoblast differentiation mediated by bone morphogenetic proteins,Hedgehogs and Cbfal[J].Endocrine Reviews 2000,21(4):393-411
[258]Ishida W,Hamamoto T,Kusanagi K,Yagi K,Kawabata M,Takehara K,Sampath TK,Kato M,Miyazono K.Smad6 is a Smad1/5-induced smad inhibitor.Characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter [J].The Journal Of Biological Chemistry 2000,275(9):6075-6079
[259]Chen D,Ji X,Harris MA,Feng JQ,Karsenty G,Celeste AJ,Rosen V,Mundy GR,Harris SE.Differential roles for bone morphogenetic protein (BMP)receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages [J].The Journal Of Cell Biology 1998,142(1):295-305
[260]Cheng H,Jiang W,Phillips FM,Haydon RC,Peng Y,Zhou L,Luu HH,An N,Breyer B,Vanichakarn P,Szatkowski JP,Park JY,He TC.Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs)[J].The Journal Of Bone And Joint Surgery.American Volume 2003,85(8):1544-1552
[261]Onishi T,Ishidou Y,Nagamine T,Yone K,Imamura T,Kato M,Sampath TK,ten Dijke P,Sakou T.Distinct and overlapping patterns of localization of bone morphogenetic protein(BMP)family members and a BMP type Ⅱ receptor during fracture healing in rats[J].Bone 1998,22(6):605-612
[262]Imamura T;Maeda S,Hayashi M.Regulation of BMP signaling[J].Clinical Calcium 2006,16(5):738-744
[263]Petra Simic,Slobodan Vukicevic.Bone morphogenetic proteins:from developmental signals to tissue regeneration.Conference on bone morphogenetic proteins.EMBO reports.2007,8(4):327-331
[264]Fumitaka Kugimiya,FumikoYano,ShinsukeOhba,Kazuyo Igawa,Kozo Nakamura,Hiroshi Kawaguchi,Ung-il Chung.Mechanism of osteogenic induction by FK506 via BMP/Smad pathways[J].Biochemical and Biophysical Research Communications 2005,(338):872-879
[265]Ippei Kanazawa,Torn Yamaguchi,Shozo Yano,Mika Yamauchi,Toshitsugu Sugimoto.Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2 expression[J].Biochemical and Biophysical Research Communications 2008,375(8):414-419
[266]Wei Zhu,Jaehon Kim,Christina Cheng,Bernard A.Rawlins,Oheneba Boachie-Adjei,Ronald G.Crystal,Chisa Hidaka.Noggin regulation of bone morphogenetic protein(BMP)2/7 heterodimer activity invitro[J].Bone 2006,(39):61-69